Vape 10-Q15 May 152015 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Mar. 31, 2015	15-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	Vape Holdings, Inc.
Entity Central Index Key	1455819
Amendment Flag	FALSE
Current Fiscal Year End Date	-21
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2015
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		11,383,505

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Sep. 30, 2014
Current assets:
Cash	$241,691	$48,370
Accounts receivable	30,612	16,771
Inventory	425,144	227,530
Prepaid inventory	109,475	246,491
Other current assets	33,427	44,100
Deferred financing costs	39,394
Total current assets	879,743	583,262
Fixed assets, net of accumulated depreciation	119,308	106,377
Trademarks	123,150	119,575
Pending patents	20,420	14,890
Deferred financing costs, long-term	5,105
TOTAL ASSETS	1,147,726	824,104
Current liabilities:
Accounts payable	171,136	216,388
Accrued expenses	84,807	169,513
Customer deposits	1,275
Convertible notes payable, net of unamortized discount of $256,285 and $32,333, respectively	640,383	187,667
Related party convertible notes payable, net of unamortized discount of $4,168 at September 30, 2014		45,832
Total current liabilities	897,601	619,400
Long term liabilities:
Convertible notes payable, long-term, net of unamortized discount of $24,222 and $19,800, respectively	69,110	178,200
Related party convertible notes payable, long-term, net of unamortized discount of $125,480 at September 30, 2014		199,115
Related party notes payable, long-term	265,000	341,290
Warrant liability	639,753	2,464,232
Total liabilities	1,871,464	3,802,237
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.00001 par value - 100,000,000 authorized; 500,000 outstanding at March 31, 2015 and September 30, 2014
Common stock, $0.00001 par value - authorized 1,000,000,000 shares; 11,824,130 issued at March 31, 2015, 11,383,505 outstanding at March 31, 2015, and 10,032,436 issued and outstanding at September 30, 2014	114	100
Additional paid-in capital	24,356,519	22,402,662
Treasury stock, 440,625 at March 31, 2015	-367,531
Accumulated deficit	-24,712,840	-25,380,895
Total stockholders' deficit	-723,738	-2,978,133
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$1,147,726	$824,104

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (Unaudited) (USD $)	Mar. 31, 2015	Sep. 30, 2014
Balance Sheets [Abstract]
Unamortized discount convertible notes payable, current	$256,285	$32,333
Unamortized discount related party convertible notes payable, current		4,168
Unamortized discount convertible notes payable, non current	24,222	19,800
Unamortized discount related party convertible notes payable, non current		$125,480
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares outstanding	500,000	500,000
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	11,824,130	10,032,436
Common stock, shares outstanding	11,383,505	10,032,436
Treasury stock, shares	440,625

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended				6 Months Ended
Consolidated Statements of Operations (Unaudited) (USD $)	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Revenue
Ceramics	$396,100		$30,759		$782,743		$30,759
Merchandise	19,159				19,159
Total revenue	415,259		30,759		801,902		30,759
Cost of revenue
Ceramics [A]	280,828	[1]	9,621	[1]	430,714	[1]	9,621	[1]
Merchandise	16,814				16,814
Total cost of revenue	297,642		9,621		447,528		9,621
Gross profit	117,617		21,138		354,374		21,138
Operating expense:
Sales and Marketing [B]	296,058	[2]		[2]	365,338	[2]		[2]
Research and development	200		29,087		52,053		37,587
General and administrative [C]	398,343	[3]	207,851	[3]	1,373,050	[3]	418,170	[3]
Total operating expenses	694,601		236,938		1,790,441		455,757
Operating loss	-576,984		-215,800		-1,436,067		-434,619
Other income (expense):
Interest expense	-93,488		-51,659		-171,478		-51,659
Interest expense - related party	-6,587		-9,061		-152,150		-57,569
Change in warrant liability	414,654		-29,528,844		1,824,479		-29,528,844
Gain on settlement	367,531				625,461
Loss on debt modification	-19,981				-19,981
Total other income (expense), net	662,129		-29,589,564		2,106,331		-29,638,072
Income (loss) before provision for income taxes	85,145		-29,805,364		670,264		-30,072,691
Provision for income taxes					2,209
Net income (loss)	$85,145		($29,805,364)		$668,055		($30,072,691)
Net income (loss) available to common shareholders:
Earnings (loss) per common share - basic	$0.02		($4.75)		$0.09		($4.69)
Earnings (loss) per common share - diluted	$0.01		($4.75)		$0.07		($4.69)
Weighted average shares - basic	11,148,666		6,278,464		10,918,103		6,415,512
Weighted average shares - diluted	13,871,488		6,278,464		13,605,046		6,415,512

[1]	Stock-based compensation was $0 and $0, and $48,483 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.
[2]	Stock-based compensation was $0 and $0, and $140,886 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.
[3]	Stock-based compensation was $0 and $0, and $636,683 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations (Unaudited) (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Stock-based compensation			$826,052
Ceramics [Member]
Stock-based compensation	0	0	48,483	0
Sales and Marketing [Member]
Stock-based compensation	0	0	140,886	0
General and Administrative [Member]
Stock-based compensation	$0	$0	$636,683	$0

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Deficit (Unaudited) (USD $)	Total	Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock
Balance at Sep. 30, 2014	($2,978,133)		$100	$22,402,662	($25,380,895)
Balance, Shares at Sep. 30, 2014		500,000	10,032,436
Conversion of related party notes payable and accrued interest	341,746		5	341,741
Conversion of related party notes payable and accrued interest, Shares			625,477
Conversion of note payables and accrued interest	370,260		3	370,257
Conversion of note payables and accrued interest, Shares			507,764
Conversion of unpaid wages	96,487		2	96,485
Conversion of unpaid wages share			158,175
Common stock issued for services	36,769		1	36,768
Common stock issued for services, Shares			60,277
Common stock issued for bonuses	288,203		7	288,196
Common stock issued for bonuses, Shares			440,001
Discount on convertible note payable at 10%	252,079			252,079
Discount on related party convertible note payable at 6%	5,410			5,410
Extinguishment of related party accrued interest	1,625			1,625
Modification of convertible notes payable	23,443			23,443
Stock-based compensation - employee options	466,587			466,587
Stock-based compensation - non-employee options	71,262			71,262
Treasury stock	-367,531		-4	4		-367,531
Treasury stock, Share			-440,625
Net income	668,055				668,055
Ending Balance at Mar. 31, 2015	($723,738)		$114	$24,356,519	($24,712,840)	($367,531)
Ending Balance, Shares at Mar. 31, 2015		500,000	11,383,505

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Deficit (Parenthetical) (Unaudited)	6 Months Ended
	Mar. 31, 2015
Statement of Stockholders' Equity [Abstract]
Discount on convertible note payable percentage	10.00%
Discount on related party convertible note payable	6.00%

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
Consolidated Statements of Cash Flows (Unaudited) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net income (loss)	$668,055	($30,072,691)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	29,815
Accretion of debt discounts	101,881	175,856
Interest expense	122,909
Gain on change in warrant liability	-1,824,479	29,528,844
Gain on settlement	-625,461
Loss on debt modification	19,981
Fair value of officer services		15,000
Common stock issued for services	36,769	102,000
Stock-based compensation	826,052
Changes in operating assets and liabilities:
Accounts receivable	-13,841	-5,745
Inventory	-60,598	-30,004
Other assets	10,673	-134,181
Accounts payable	149,747	156,173
Accrued expenses	67,292	12,478
Customer deposits	1,275
Net cash used in operating activities	-489,930	-252,270
Cash flows from investing activities:
Capital expenditures	-42,746	-42,989
Purchase of trademarks and pending patents	-9,105
Net proceeds from settlement	62,930
Net cash provided by (used in) investing activities	11,079	-42,989
Cash flows from financing activities:
Net proceeds from issuance of convertible notes payable	835,000	448,000
Net proceeds from issuance of related party convertible notes payable		340,287
Net proceeds from issuance of notes payable		242,593
Repayments on convertible notes payable	-40,000
Repayments on related party convertible notes payable	-50,000
Repayments on related party notes payable	-72,828	-137,236
Net cash provided by financing activities	672,172	893,644
Net change in cash	193,321	598,385
Cash, beginning of period	48,370	568
Cash, end of period	241,691	598,953
Cash paid during the period for:
Interest	18,788
Taxes	2,209
Non-cash investing and financing activities:
Conversion of notes payable and accrued interest	370,260
Conversion of related party notes payable and accrued interest	341,747	64,951
Issuance of convertible note payable for services		100,000
Issuance of convertible note payable for former officer services		50,000
Issuance of common stock in connection with warrant settlement		98,822
Beneficial conversion feature recorded with convertible notes payable	252,079
Beneficial conversion feature recorded with related party convertible note payable	5,410
Original issue discount recorded with convertible notes payable	$257,489

Description_of_Business_and_Su

Description of Business and Summary of Significant Accounting Policies	6 Months Ended
	Mar. 31, 2015
Description of Business and Summary of Significant Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



	BUSINESS



	Vape Holdings, Inc. (“VAPE,” the “Company,” “we,” “us,” “our,” “our company”) is a holding company with its primary focus in the manufacturing and distribution of healthy and sustainable vaporization products. The Company designs, markets and distributes ceramic vaporization products under a unique brand. The Company has introduced a nonporous, non-corrosive, chemically inert medical-grade ceramic vaporization element as a healthy, sustainable alternative to traditional titanium and quartz vaporization materials, as well as lower-grade ceramic found in traditional electronic cigarettes and vaporizers. This material can be used for a wide range of applications, including stand-alone vaporization products and "E-cigs." Electronic cigarettes come in a variety of designs ranging from those that look vastly like traditional cigarettes, to larger vaporizer units which are capable of vaporizing liquid with varying viscosity. The process of vaporization is believed to eliminate the smoke, tar, ash, and other byproducts of traditional smoking by utilizing lower temperatures in a controlled electronic environment.



	HIVE



	HIVE Ceramics (“HIVE”) is the premier brand under the VAPE umbrella. HIVE manufactures and distributes a proprietarily blended ceramic vaporization element for torched, electronic and portable vaporizers with countless design and product crossover capabilities in existing and emerging markets. HIVE is dedicated to bringing the healthiest and cleanest vaporization experience possible to the market. The HIVE product line currently consists of over 15 distinct ceramic elements, including the 2 piece domeless, domeless direct inject, and HIVE’s signature domeless elements covering 10mm, 14mm and 18mm applications as well as regular elements, the HIVE Flower Cup, the HIVE Carb Cap, HIVE Stinger Dabber, the 14mm HIVE x Quave - Club Banger, and the HIVE x D-Nail 16mm and 20mm attachments.



	The Company has recently launched ‘HIVE Glass.’ HIVE Glass is VAPE’s newest line of products under the HIVE brand name. The HIVE GLASS line is precision made using state of the art manufacturing processes and techniques, and exclusively uses German Schott glass caliber and fittings through all production phases. The aim with HIVE Glass is to create an affordable, high quality glass product that is both aesthetically pleasing and a highly functional vaporization product. VAPE’s existing customer base and distribution network will be the catalyst for expansion of this new HIVE product line.



	VAPE has also recently launched ‘HIVE Supply’. HIVE Supply is a packaging and sourcing division of VAPE designed to serve as a competitively priced, comprehensive “one-stop shop” for all medical and recreational marijuana packaging needs. As with all of VAPE’s products, HIVE Supply will operate in full compliance with all federal laws and the laws of each individual state in which it does business. HIVE Supply will focus on providing much-needed support to legal cannabis businesses in regards to sourcing consumer products, brand management and marketing services. HIVE Supply is currently operated out of three (3) locations: HIVE Supply in Southern California, HIVE Supply Washington in Spokane and HIVE Supply Oregon in Portland.



	In connection with its launch of HIVE Supply and HIVE Glass, the Company opened ‘THE HIVE’ retail store and gallery in Los Angeles, an end-user experience to showcase the complete line of HIVE Ceramics and HIVE Glass products, while introducing HIVE Supply and all the new products being tested and developed through each vertical.



	The Company intends to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has created or acquired and continues in the process of creating and/or acquiring proprietary vaporizers and e-cigarettes, and various trademarks, patents and copyrights for brands which are developed or in development. The Company is actively engaged in improving and expanding lines of branded products through business alliances and acquisitions, as well as developing its branded retail business expansion. VAPE and its business units are organized and directed to operate strictly in accordance with all applicable state and federal laws.



	MANAGEMENT’S PLANS



	VAPE’s consolidated financial statements reflect net loss from operations of $1,436,067 during the six months ended March 31, 2015. As of March 31, 2015, we had cash of $241,691 and a working capital deficit of $17,858. Management has subsequently obtained funding for operations described below. Although there is a risk of default as the funding is subject to completion, we believe our current liquidity and securities purchase commitments will be sufficient to continue operating as a going concern through March 2016.



	If current and projected revenue growth does not meet our estimates, we may choose to raise additional capital through debt and/or equity transactions, renegotiate current convertible debt obligations, reduce certain overhead costs through the deferral of salaries and other means, and settle liabilities through negotiation. Currently, we cannot provide assurance that such financing will be available to us on favorable terms, or at all. If, after utilizing the existing sources of capital available to us, further capital needs are identified and if we are not successful in obtaining the financing, we may be forced to curtail our existing or planned future operations.



	OFFSET



	On January 22, 2015, the Company created a new wholly-owned subsidiary, Offset, LLC (“Offset”), which is in the business of branding, marketing, and merchandising services. Offset will serve as VAPE’s creative marketing, branding and merchandising vehicle working synergistically with VAPE’s existing product lines, sales and distribution channels, HIVE Supply retail development while expanding into unique branding, marketing and merchandising avenues both inside and outside of the legal cannabis industry.



	NOUVEAU



	On April 6, 2015, the Company created a new wholly-owned subsidiary, Nouveau, LLC (“Nouveau”), which is in the business of branding, marketing, and web design services. Nouveau will serve as VAPE’s creative marketing, branding, and web design vehicle working synergistically with VAPE’s existing product lines, sales and distribution channels, HIVE Supply retail development while expanding into unique branding, marketing and merchandising avenues both inside and outside of the legal cannabis industry.



MANAGEMENT SERVICES AND REAL ESTATE SOLUTIONS



VAPE also plans to leverage its management team’s vast experience in the legal cannabis concentrate industry to provide management, consulting, branding, real estate and compliant packaging solutions to lawfully operating participants in the legal cannabis industry. Although the Company plans to provide services to the industry, it does not grow, transport, harvest, or sell cannabis. Furthermore, it does not currently maintain an ownership interest in any extraction laboratories or concentrate facilities. As for its real estate services, the Company plans to hold properties in strategic locations deemed to be susceptible for large scale manufacturing and extraction of concentrates. VAPE plans to purchase this real estate, build the full-scale infrastructure needed for these cultivation and extraction laboratories and then lease the real estate, equipment and infrastructure to these compliant cultivators. The Company also plans to provide property management and leasing services to legally compliant legal cannabis facilities. The Company plans to provide guidance and expertise to assist in the development of standardized labs, processes and packaging. To that end, the Company plans to work closely with the leaders in cultivation, extraction and lab testing in the most relevant markets to form a positive working group to set the standard for how these products are made, packaged and responsibly advertised. VAPE plans to forge strategic relationships in the legal concentrate industry, develop intellectual property and standardize the build-out and process of concentrate manufacturing facilities. VAPE has already begun deploying management and consultants into areas of interest to evaluate opportunities in this rapidly growing industry.



VAPE is organized and directed to operate strictly in accordance with all applicable state and federal laws.

Accounting_Policies_and_Basis_

Accounting Policies and Basis of Presentation	6 Months Ended
Accounting Policies and Basis of Presentation	Mar. 31, 2015
Accounting Policies and Basis of Presentation [Abstract]
ACCOUNTING POLICIES AND BASIS OF PRESENTATION	NOTE 2. ACCOUNTING POLICIES AND BASIS OF PRESENTATION



	BASIS OF PRESENTATION



	The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. The current results are not an indication of the full year.



	CONSOLIDATION



	The consolidated financial statements include the assets, liabilities, and operating results of the Company and its wholly-owned subsidiaries, HIVE and Offset after elimination of all material inter-company accounts and transactions.



	USE OF ESTIMATES



	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes.



	FAIR VALUE OF FINANCIAL INSTRUMENTS



	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value:



		Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
		Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
		Level 3 - Unobservable inputs which are supported by little or no market activity.



	The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Derivative instruments include the warrant liability (Level 2). Derivative instruments are valued using standard calculations/models that are primarily based on observable inputs, including volatilities and interest rates. Therefore, derivative instruments are included in Level 2.



	Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2015 and September 30, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses, accounts payable, accrued liabilities, and notes payable. Fair values for these items were assumed to approximate carrying values because of their short-term nature or they are payable on demand.



	The following table presents the Company’s fair value hierarchy for assets measured at fair value on a recurring basis at March 31, 2015:



			Level 1			Level 2			Level 3			Total
	Assets
	Cash and cash equivalents		$	241,691		$	-		$	-		$	241,691
	Total assets measured at fair value		$	241,691		$	-		$	-		$	241,691

	Liabilities
	Derivative instruments		$	-		$	639,753		$	-		$	639,753
	Total liabilities measured at fair value		$	-		$	639,753		$	-		$	639,753



The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at September 30, 2014:



		Level 1			Level 2			Level 3			Total
Assets
Cash and cash equivalents		$	48,370		$	-		$	-		$	48,370
Total assets measured at fair value		$	48,370		$	-		$	-		$	48,370

Liabilities
Derivative instruments		$	-		$	2,464,232		$	-		$	2,464,232
Total liabilities measured at fair value		$	-		$	2,464,232		$	-		$	2,464,232



CONCENTRATION



Credit Risk



At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant write-offs of potentially uncollectible accounts.



Supplier



Two (2) suppliers and one (1) supplier accounted for 79% and 70% of our purchases during the three and six months ended March 31, 2015. The loss of these suppliers would have a significant impact on the Company’s financial results.



REVENUE RECOGNITION



The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured. Revenue is recorded when sales orders are shipped.



INVENTORY



Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value.



We purchase product sourced from China which we are required to pay 50% upon placing the order. Amounts paid for products, which have not been received, are recorded as prepaid inventory. There are no amounts paid which are in dispute or considered impaired.



FIXED ASSETS



Fixed assets are recorded at cost and depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The estimated life of tooling related to our ceramic products is three (3) years. The estimated life of our leasehold improvements is the lesser of the term of the related lease and useful life.



IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS



The Company has adopted Accounting Standards Codification (“ASC”) 350 “Intangibles - Goodwill and Other.” The Statement requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 350 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.



Long-lived assets, such as fixed assets and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management's best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. During the three and six months ended March 31, 2015 and 2014, the Company did not record any impairment of its trademarks and pending patents as its expected future cash flows are in excess of their carrying amounts.



RESEARCH AND DEVELOPMENT



Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as fixed assets and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the six months ended March 31, 2015 and 2014, research and development costs were $52,053 and $37,587, respectively.



CONVERTIBLE DEBT



Convertible debt is accounted for under the guidelines established by ASC 470-20 “Debt with Conversion and Other Options”. ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt. Many of the conversion features embedded in the Company's convertible notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. The management and board of directors currently have the ability to authorize additional shares of common stock primarily through their super voting rights under the Series A Preferred stock (See “NOTE 8 - STOCKHOLDERS’ DEFICIT”).



When applicable, the Company calculates the fair value of warrants and conversion features issued with the convertible instruments using the Black-Scholes valuation method, using the same assumptions used for valuing employee options for purposes of ASC 718 “Compensation - Stock Compensation”, except that the contractual life of the warrant or conversion feature is used. Under these guidelines, the Company allocates the value of the proceeds received from a convertible debt transaction between the conversion feature and any other detachable instruments (such as warrants) on a relative fair value basis. The allocated fair value is recorded as a debt discount or premium and is amortized over the expected term of the convertible debt to interest expense. If the fair value exceeds the carrying value of the debt, an immediate charge to operations is recorded by management. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations. Currently no instruments are being recorded as such.



The Company accounts for modifications of its BCF’s in accordance with ASC 470-50 “Modifications and Extinguishments.” ASC 470-50 requires the modification of a convertible debt instrument that changes the fair value of an embedded conversion feature and the subsequent recognition of interest expense or the associated debt instrument when the modification does not result in a debt extinguishment.



DERIVATIVE FINANCIAL INSTRUMENTS



Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets.



The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has issued financial instruments including senior convertible notes payable and freestanding stock purchase warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by ASC 815, in certain instances, these instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements.



The Company estimates the fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with objectively measuring fair values. In selecting the appropriate technique, consideration is given to, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, the Company generally uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, the Company's operating results will reflect the volatility in these estimate and assumption changes.



EARNINGS PER COMMON SHARE



Basic earnings per common share is computed by dividing net income available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing net income available to common shareholders by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated, based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the estimated tax benefits that would be recorded in paid-in capital, if any, when an award is settled are assumed to be used to repurchase shares in the current period.



The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders:



		For the Three Months Ended			For the Six Months Ended
			31-Mar-15			31-Mar-15
Weighted average common shares outstanding used in calculating basic earnings per share			11,148,666			10,918,103
Effect of preferred stock			500,000			500,000
Effect of convertible notes payable			2,025,679			2,025,679
Effect of options and warrants			197,143			161,264
Weighted average common and common equivalent shares used in calculating diluted earnings per share			13,871,488			13,605,046

Net income as reported		$	85,145		$	668,055
Add - interest on convertible notes payable			100,075			323,506
Net income available to common stockholders		$	185,220		$	991,561



The Company excluded 751,250 and 502,500 options from the computation for the three and six months ended March 31, 2015, as their exercise prices were in excess of the average closing market price of the Company’s common stock, causing their effects to be anti-dilutive using the treasury stock method.



During the three and six months ended March 31, 2014, 642,346 convertible note shares would have been included in the computation of dilutive shares outstanding since the exercise prices did not exceed the average market value of the Company's common stock if the Company generated net income. During the three and six months ended March 31, 2014, no options and warrants would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company's common stock.



STOCK-BASED COMPENSATION



ASC 718, “Share-Based Payment” requires that compensation cost related to share-based payment transactions be recognized in the consolidated financial statements. Share-based payment transactions within the scope of ASC 718 include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans.



The Company adopted ASC 718, which requires disclosure of the fair value and other characteristics of stock options and more prominent disclosure about the effects of an entity’s accounting policy decisions with respect to stock-based compensation on reported net loss. The Company has reflected the expense of such stock based compensation based on the fair value at the grant date for awards consistent with the provisions of ASC 718.



In connection with the adoption of ASC 718, the fair value of our share-based compensation has been determined utilizing the Black-Scholes pricing model. The fair value of the options granted is amortized as compensation expense on a straight line basis over the requisite service period of the award, which is generally the vesting period. The fair value calculations involve significant judgments, assumptions, estimates and complexities that impact the amount of compensation expense to be recorded in current and future periods. Upon option exercise, the Company issues new shares of stock.



The following weighted average variables were used in the Black Scholes model for all option issuances valued during the six months ended March 31, 2015 and 2014:



Six Months		Stock Price at			Dividend			Exercise			Risk Free			Volatility			Average
Ended		Grant Date			Yield			Price			Interest Rate						Life
March 31,
2015		$	0.73			-%		$	0.73			2.2	%		380	%		10
2014			n/a			n/a			n/a			n/a			n/a			n/a



The Company's accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of Emerging Issues Task Force (“EITF”) 96-18, “Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services”, codified into ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.



RECENT ACCOUNTING PRONOUNCEMENTS



In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers”, which supersedes most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for these goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. This guidance is effective for the Company in the first quarter of fiscal year 2018 and early application is not permitted. Entities must adopt the new guidance using one of two retrospective application methods. The Company is currently evaluating the standard but does not expect it to have a material impact on our financial position, results of operations or cash flows.



The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.



RISKS AND UNCERTAINTIES



Although forward-looking statements in this Quarterly Report reflect our good faith judgment, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include without limitation those discussed under the heading “Risk Factors” below, as well as those discussed elsewhere in this Quarterly Report. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Fixed_Assets

Fixed Assets	6 Months Ended
	Mar. 31, 2015
Fixed Assets [Abstract]
FIXED ASSETS	NOTE 3. FIXED ASSETS



	The following is a summary of fixed assets as of March 31, 2015 and September 30, 2014:



		March 31,			September 30,
		2015			2014
	Molds and Tooling	$	135,505		$	122,555
	Leasehold improvements		29,795			-
	Accumulated depreciation		(45,992	)		(16,178	)
		$	119,308		$	106,377



	During the six months ended March 31, 2015 and 2014, depreciation expense included in cost of revenue were $29,815 and $0, respectively.

Accrued_Expenses

Accrued Expenses	6 Months Ended
Accrued Expenses	Mar. 31, 2015
Accrued Expenses [Abstract]
ACCRUED EXPENSES	NOTE 4. ACCRUED EXPENSES



	The following is a summary of accrued expenses as of March 31, 2015 and September 30, 2014:

		March 31, 2015		September 30,
		March 31, 2015		2014
	Accrued interest	$	22,841	$	16,300
	Accrued interest - related party		16,460		18,325
	Accrued wages and taxes		27,779		108,374
	Other		17,727		26,514
		$	84,807	$	169,513

Third_Party_Debt

Third Party Debt	6 Months Ended
Third Party Debt	Mar. 31, 2015
Third Party Debt [Abstract]
THIRD PARTY DEBT	NOTE 5. THIRD PARTY DEBT



	CONVERTIBLE NOTES PAYABLE



	Beginning on February 11, 2014, the Company issued 6% Convertible Notes (the “6% Notes”) pursuant to subscription agreements to ten (10) accredited investors (the “Holders”) with the aggregate principal amount of $230,000. The 6% Notes are not secured by any collateral or any assets pledged to the Holders. The maturity dates are from February 28, 2015 to March 31, 2015, and the annual rate of interest is six percent (6%). Subject to certain limitations, the Holders can, at their sole discretion, convert the outstanding and unpaid principal and interest of their notes into fully paid and nonassessable shares of the Company’s common stock. The conversion price of these 6% Notes is the average of the fifteen (15) lowest daily VWAP’s occurring during the twenty (20) consecutive trading days immediately preceding the date each Holder elects convert all of their 6% Note minus a discount of 40%. In no event will the conversion price be less than $1.00 per share or greater than $3.00 per share. The Company had a preexisting relationship with each of the Holders, and no general solicitation or advertising was used in connection with the issuance of the 6% Notes. We recorded a discount totaling $92,000 related to the beneficial conversion feature embedded in the notes upon issuance and amortized $11,235 and $33,235 of the discount to interest expense during the three and six months ended March 31, 2015, respectively.



	On March 12, 2015, the Company offered to pay accrued interest and modify the terms of the six (6) Holders’ outstanding 6% Notes, decreasing the conversion floor from $1.00 to $0.50 in order to encourage the noteholders to convert their promissory notes. The Company recorded a loss on debt modification of $23,443 as a result of the fair value in excess of the modified conversion floor. In March 2015, the Company paid all accrued interest on the 6% notes of $17,200. Five (5) of the six (6) holders converted in full a total of $80,000 of 6% Notes into 160,000 shares of common stock. The remaining note holder partially converted $20,000 of 6% Notes into 40,000 of common shares and extended the terms on the remaining $30,000 for six (6) months. As of March 31, 2015, there is $95 in accrued interest expense related to the one (1) remaining note and the Company recorded $2,086 and $5,458 in interest expense related to the 6% notes during the three and six months ended March 31, 2015, respectively.



	On December 3, 2014, Vape Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an accredited investor (the “Investor”) pursuant to which the Company agreed to sell, and the Investor agreed to purchase, an unsecured convertible promissory note (the “Note”) in the principal amount of $560,000 less an original issue discount (“OID”) of $50,000 and transaction expenses of $10,000 for a total purchase price of $500,000. The Company also paid a finder’s fee in the amount of $25,000 in connection with this transaction, which was recorded as a discount to the note as it was paid from the proceeds. The closing under the Securities Purchase Agreement occurred on December 3, 2014. The Company received $475,000 net proceeds after transactions costs. We amortized $8,333 and $11,111 of the discount to interest expense during the three and six months ended March 31, 2015. In addition, the Company recorded $45,940 in deferred financing costs and amortized $7,657 and $10,209 to interest expense during the three and six months ended March 31, 2015, respectively. As of March 31, 2015, the Company capitalized $30,627 and $5,104 as current and long-term deferred financing costs, respectively.



	The Note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at a conversion price per share of 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable Conversion (subject to adjustment in the event of stock splits, stock dividends, and similar transactions, and in the event of subsequent sales of common stock at a lower purchase price (subject to certain exceptions))(the “Conversion Price”). In no event will the Conversion Price be less than $0.50 per share. Repayment of principal on the Note, together with accrued interest thereon, is due in twelve monthly installments, commencing six months from issuance. The Company may make such payments in cash (in which event the Company will pay a 25% premium) or, subject to certain conditions, in shares of common stock valued at the lower of the Conversion Price or 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable payment date. The Maturity Date of the Note is seventeen months from the date of issuance. We recorded a discount totaling $168,000 related to the beneficial conversion feature embedded in the note upon issuance. We amortized $28,000 and $37,333 of the discount to interest expense during the three and six months ended March 31, 2015. As of March 31, 2015, $321,333 and $69,111, net of total unamortized discounts of $145,333 and $24,222, respectively are classified as current and long-term on the accompanying consolidated balance sheet. As of March 31, 2015, there is $18,356 in accrued interest expense related to these notes and the Company recorded $14,000 and $18,356 in interest expense related to this note during the three and six months ended March 31, 2015.



	$2M Securities Purchase Agreement



	On February 10, 2015, the Company entered into a securities purchase agreement (the “February 2015 Securities Purchase Agreement”) with an accredited investor pursuant to which the Company agreed to sell, and the investor agreed to purchase, an unsecured convertible promissory note (the “$2M Note”) in the principal amount of $2,000,000 less an original issue discount (“OID”) of $182,000 and transaction expenses of $10,000 for a total purchase price of $1,808,000. The closing under the February 2015 Securities Purchase Agreement occurred on February 10, 2015.



	The $2M Note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at a conversion price per share of 70% of the lowest daily VWAP in the ten (10) Trading Days immediately preceding the applicable Conversion (subject to adjustment in the event of stock splits, stock dividends, and similar transactions, and in the event of subsequent sales of common stock at a lower purchase price (subject to certain exceptions))(the “Conversion Price”). In no event will the Conversion Price be less than $0.50 per share. Repayment of principal on the $2M Note, together with accrued interest thereon, is due in twelve bi-monthly installments, commencing approximately six months from issuance. The Company may make such payments in cash (in which event the Company will pay a 25% premium) or, subject to certain conditions, in shares of common stock valued at the lower of the Conversion Price or 70% of the lowest daily VWAP in the ten (10) Trading Days immediately preceding the applicable payment date. The Maturity Date of the $2M Note is twelve months from the date of issuance.



	During the three and six months ended March 31, 2015, the Company received $400,000 toward the $2M Note with an original issue discount of $38,400 for net proceeds of $361,600. We amortized $3,200 of the discount to interest expense during the three and six months ended March 31, 2015. In addition, we recorded a discount totaling $168,000 related to the beneficial conversion feature embedded in the note upon issuance. We amortized $11,235 of the discount to interest expense during the three and six months ended March 31, 2015. As of March 31, 2015, $293,556, net of total unamortized discounts of $106,444 are classified as current on the accompanying consolidated balance sheet. As of March 31, 2015, there is $4,389 in accrued interest expense related to the $2M Note and the Company recorded $4,389 in interest expense related to this note during the three and six months ended March 31, 2015. Subsequent to March 31, 2015, we received another $361,600 towards the $2M Note.



	The Company has the ability to increase the authorized common stock of the Company in the event that the convertible notes require more shares than available.



	CONVERTIBLE NOTES PAYABLE, LONG-TERM



	On March 19, 2014, the Company issued an 8% Convertible Note to W-net Fund I, LP in exchange for the contribution of capital to the Company in the amount of $198,000 (the “W-net Note”). Per the terms of the W-net Note, the principal balance is $198,000, and is not secured by any collateral or any assets pledged to the holder. The maturity date is November 19, 2014 and interest accrues at 8% per annum. Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the W-net Note is eighty percent (80%) of the average of the three (3) lowest daily closing bid prices (the 3 lowest prices will be calculated on a VWAP basis) occurring during the ten (10) consecutive Trading Days immediately preceding the applicable conversion date on which the holder elects to convert. In no event shall the conversion price be less than $1.00 or greater than $3.00. We recorded a discount totaling $158,400 related to the beneficial conversion feature embedded in the notes upon issuance. On June 2, 2014, the W-net Note was assigned in its entirety to a third party free of any liens or encumbrances. On October 28, 2014, the Company received a Notice of Conversion for the W-net Note. The noteholder converted principal of $198,000 and outstanding accrued and unpaid interest of $9,764 into 207,764 shares of restricted common stock of the Company at a per share conversion price of $1.00 in accordance with the terms of the convertible note payable. The conversion of this note was in full satisfaction of the note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $19,800 to interest expense.

Related_Party_Debt

Related Party Debt	6 Months Ended
Related Party Debt	Mar. 31, 2015
Related Party Debt [Abstract]
RELATED PARTY DEBT	NOTE 6. RELATED PARTY DEBT



	RELATED PARTY NOTES PAYABLE, LONG-TERM




	The Company had outstanding accounts payable balance to a related party (shareholder of the Company) in the amount of $15,000 as of September 30, 2013. This payable was converted into a note payable on December 7, 2013. The note payable bears interest of 6% per annum with a maturity date of December 1, 2016. As of March 31, 2015, there is $1,189 in accrued interest expense related to this note and the Company recorded $226 and $457 in interest expense related to this note during the three and six months ended March 31, 2015.



	On December 7, 2013, the Company issued a note payable to a shareholder of the Company in the amount of $23,462 for monies previously borrowed from shareholder. The note is unsecured and bears interest of 6% per annum and matures on December 1, 2016. On January 22, 2015, the Company settled and paid the note and accrued interest of $1,504 for $20,000 and recorded a gain on extinguishment of the note of $3,462.



	On February 28, 2014, the Company issued a note payable to HIVE (the “HIVE Note) for the principal amount of $250,000 in connection with the Hive asset acquisition. Per the terms of the HIVE Note, the maturity date is February 27, 2016 and the annual rate of interest is six percent (6%). No prepayment penalty exists. The HIVE Note is unsecured. As of March 31, 2015, there is $15,270 in accrued interest expense related to this note and the Company recorded $3,751 and $7,585 in interest expense related to this note during the three and six months ended March 31, 2015, respectively.



	On May 12, 2014, the Company issued a note payable to its President, Joseph Andreae in the amount of $40,000 for monies previously borrowed during the three and six months ended March 31, 2014 (the “Andreae Note”). The note was unsecured and bears interest of 6% per annum and matures on May 1, 2016. On December 4, 2014, the Company repaid the principal balance of $40,000 and accrued interest of $1,348 in full satisfaction on the Andreae Note.



	On August 11, 2014, the Company issued a 6% note payable to its President, Joseph Andreae, for monies borrowed from Mr. Andreae to cover outstanding accounts payable in the amount of $12,828 (the “Andreae Note II”). Per the terms of the Andreae Note, the original principal balance was $12,828, and was not secured by any collateral or any assets pledged to the holder. The maturity date is November 30, 2014, and the annual rate of interest is six percent (6%). The monies were funded during the three and nine months ended June 30, 2014. On December 4, 2014, the Company repaid principal balance of $12,828 and accrued interest of $240 in full satisfaction of the Andreae Note II.



	RELATED PARTY CONVERTIBLE NOTES PAYABLE



	On February 18, 2014, the Company issued 8% Convertible Notes to two third parties to cover outstanding accounts payable in the amount of $20,000. Per the terms of the notes, the aggregate principal balance is $20,000, and was not secured by any collateral or any assets pledged to the holders. The maturity date is February 18, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holders can, at their sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the notes was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $8,000 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $1,000 and $1,667 of the discount to interest expense during the three and nine months ended June 30, 2014, respectively. On October 28, 2014, the Company received a Notice of Conversion on two (2) 8% Convertible Notes issued to third parties on February 18, 2014 to cover expenses of the Company. The noteholders converted aggregate principal of $20,000 and aggregate outstanding accrued and unpaid interest of $1,100 into an aggregate of 42,370 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of their convertible notes payable. The conversion of these notes was in full satisfaction of the notes payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $5,333 to interest expense.



	On March 17, 2014, the Company issued an 8% Convertible Note to Jerome Kaiser, former CEO, CFO and Director of the Company for services rendered to the Company in the amount of $50,000 (the “Kaiser Note”) which was charged to expense during the three months March 31, 2014. Per the terms of the Kaiser Note, the principal balance is $50,000, and is not secured by any collateral or any assets pledged to the holders. The maturity date is March 17, 2015, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at his sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Kaiser Note is the market closing price of the market day immediately preceding the date of conversion minus twenty percent (20%). We recorded a discount totaling $10,000 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $1,667 and $4,167 of the discount to interest expense during the three and six months ended March 31, 2015. In March 2015, the Company paid the outstanding principal and accrued interest in satisfaction on the note of $50,000 and $4,000, respectively.



	RELATED PARTY CONVERTIBLE NOTES PAYABLE, LONG-TERM



	On February 18, 2014, the Company issued an 8% Convertible Note to Kyle Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $10,612 (the “Tracey Note”). Per the terms of the Tracey Note, the original principal balance is $10,612, and was not secured by any collateral or any assets pledged to the holder. The maturity date was February 18, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $4,245 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $1,415 of the discount to interest expense during the year ended September 30, 2014. On October 28, 2014, the Company received a Notice of Conversion the Tracey Note. Mr. Tracey converted principal of $10,612 and outstanding accrued and unpaid interest of $584 into 22,481 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of the convertible note payable. The conversion of the Tracey Note was in full satisfaction of the note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $2,830 to interest expense.



	On May 12, 2014, in connection with the 6% Notes, the Company issued a note for $40,000 to Kyle Tracey, which was recorded as a related party convertible note payable. We recorded a discount totaling $16,000 related to the beneficial conversion feature embedded in the 6% note to Mr. Tracey upon issuance. We amortized $6,667 of the discount to interest expense during the year ended September 30, 2014. On October 28, 2014, the Company received a Notice of Conversion on the 6% Convertible Note issued on May 13, 2014 to Mr. Tracey (the “Tracey PPM Note”) as part of a private placement transaction in exchange for capital of $40,000. Mr. Tracey converted principal of $40,000 and outstanding accrued and unpaid interest of $1,098 into 41,098 shares of restricted common stock of the Company at a per share conversion price of $1.00 in accordance with the terms of the convertible note. The conversion of the Tracey PPM Note was in full satisfaction of the note. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $13,333 to interest expense.



	On May 12, 2014, the Company issued an 8% Convertible Note to Kyle Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $11,042 (the “Tracey Note II”). Per the terms of the Tracey Note II, the original principal balance is $11,042, and was not secured by any collateral or any assets pledged to the holder. The maturity date was May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $4,417 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $920 of the discount to interest expense during the year ended September 30, 2014. On October 28, 2014, the Company received a Notice of Conversion on the Tracey Note II. Tracey converted principal of $11,042 and outstanding accrued and unpaid interest of $407 into 22,989 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of the convertible note payable. The conversion of the Tracey Note II was in full satisfaction of the note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $3,497 to interest expense.



	On May 12, 2014, the Company issued an 8% Convertible Note to its Director of Business Development, Michael Cook, for monies borrowed from Mr. Cook to cover outstanding accounts payable in the amount of $11,825 (the “Cook Note”). Per the terms of the Cook Note, the original principal balance was $11,825, and was not secured by any collateral or any assets pledged to the holder. The maturity date is May 12, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Cook Note was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $4,730 related to the beneficial conversion feature embedded in the notes upon issuance. We amortized $985 of the discount to interest expense during the year ended September 30, 2014. On October 28, 2014, the Company received a Notice of Conversion on the “Cook Note. Mr. Cook converted principal of $11,825 and outstanding accrued and unpaid interest of $435 into 24,619 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of the convertible note payable. The conversion of the Cook Note was in full satisfaction of the note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $3,745 to interest expense.


	On August 11, 2014, the Company issued a second 8% Convertible Note to Mr. Cook for monies borrowed from Mr. Cook to cover outstanding accounts payable in the amount of $15,115 (the “Cook Note II”). Per the terms of the Cook Note II, the original principal balance was $15,115, and is was secured by any collateral or any assets pledged to the holder. The maturity date is August 11 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Cook Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $6,046 related to the beneficial conversion feature embedded in the notes upon issuance. On October 28, 2014, the Company received a Notice of Conversion on the Cook Note II. Mr. Cook converted principal of $15,115 and outstanding accrued and unpaid interest of $255 into 30,864 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of the convertible note payable. The conversion of the Cook Note II was in full satisfaction of the note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $5,542 to interest expense.



On August 11, 2014, the Company issued an 8% Convertible Note to Mr. Tracey for monies borrowed from Mr. Tracey to cover outstanding accounts payable in the amount of $216,001 (the “Tracey Note III”). Per the terms of the Tracey Note III, the original principal balance was $216,001, and is not secured by any collateral or any assets pledged to the holder. The maturity date was August 11, 2016, and the annual rate of interest is eight percent (8%). Subject to certain limitations, the holder can, at its sole discretion, convert the outstanding and unpaid principal and interest into fully paid and nonassessable shares of the Company’s common stock. The conversion price for the Tracey Note III was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%). We recorded a discount totaling $86,401 related to the beneficial conversion feature embedded in the notes upon issuance. On October 28, 2014, the Company received a Notice of Conversion on the Tracey Note III. Mr. Tracey converted principal of $216,001 and outstanding accrued and unpaid interest of $3,645 into 441,057 shares of restricted common stock of the Company at a per share conversion price of $0.498 in accordance with the terms of the convertible note payable. The shares of common stock under the conversion were issued by the Company on November 7, 2014. Upon conversion, we expensed the unamortized discount of $79,200 to interest expense.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Mar. 31, 2015
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7. COMMITMENTS AND CONTINGENCIES



	Warrant Liability



	The Company recorded the estimated settlement liability as of March 31, 2014 for the Warrant Shares issued and the Warrants that remain outstanding and unexercised that would be entitled to the same settlement based on the number of shares expected to be issued and the market price of the Company’s common stock on the dates of the actual settlements from $4.72 per share to $7.25 per share, and market price of the first settlement of $7.25 for the unsettled claims. We believe the issuance of convertible notes in the three months ended March 31, 2014 triggered the full ratchet anti-dilution adjustment; before the provision was triggered, the fair value of the warrant liability was not significant as the exercise was so far out of the money. As a result of the above settlements with warrant holders, the Company recorded a loss on settlement of warrants of $29,528,844 during the six months ended March 31, 2014 and a long-term warrant liability of $29,430,022 as of March 31, 2014 based on 4,407,200 shares of common stock under the settlement at the Company’s closing stock prices discussed above. As of March 31, 2015, the estimated settlement liability is $639,753 based on the fair market value of 1,184,727 remaining warrants and therefore the Company recorded a gain on the change in warrant liability of $625,461 during the six months ended March 31, 2015.


	Settlement of Company Legal Claims



	On December 15, 2014, the Company recorded a gain on settlement of $257,930 for a confidential settlement by and between the Company and certain shareholders and related parties as settlement for certain potential legal claims held by the Company. As a result of the settlement, the Company received net proceeds of $62,930 and vendor credits of $200,000 during the three months ended December 31, 2014. A total of $325,000 in vendor credits has been received in connection with the settlement and no further credits will be given. In January 2015, the Company received 440,625 shares from the settlement that was assigned to officers of the Company. The officers decided it was in the best interest to return these shares to the Company to be used for future strategic issuances. Accordingly, the 440,625 shares valued at $367,531 were recorded as treasury stock as of March 31, 2015, and the Company recorded a gain on settlement of $367,531 and $625,461 during the three and six months ended March 31, 2015.

Stockholders_Deficit

Stockholders' Deficit	6 Months Ended
	Mar. 31, 2015
Stockholders' Deficit [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT



	COMMON STOCK



	On November 27, 2013, the board of directors and shareholders approved an increase in the authorized number of shares of common and preferred stock which may be issued by the Company to 1,000,000,000 shares and 100,000,000 shares, respectively. On December 3, 2013, the certificate of amendment was filed with the Secretary of State of Delaware to reflect the increase in authorized.



	PREFERRED STOCK



	On April 1, 2014, the Board formally approved the filing of a Preferred Stock Designation in connection with the commitment of 500,000 Series A Shares to HIVE on March 27, 2014 pursuant to its authority to issue blank check preferred stock as provided in the Company’s Certificate of Incorporation. Per the Certificate of Designation (the “Designation”), there are 100,000,000 shares of preferred stock authorized by the Company’s Certificate of Incorporation. The Company is authorized to issue 500,000 shares of Series A Shares pursuant to the Designation. As provided in the Designation (and as set forth in the HIVE Asset Purchase Agreement), Series A Shares are entitled to vote at a 15-1 ratio to Common Stock. Each share of preferred stock shall initially be convertible into one share of common stock (500,000 shares of common stock in the aggregate). On the two year anniversary of the transaction of HIVE, the preferred stock conversion ratio shall be adjusted as follows: a one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.



	On June 19, 2014, the Company formally issued the 500,000 Series A Shares to HIVE.



	The value ascribed to the Series A Shares was based on the historical costs of the assets acquired on March 27, 2014 from HIVE since the transfer of assets was made among entities under common control.



	COMMON STOCK ISSUED FOR BONUSES



	On March 12, 2015, the Company’s Board of Directors issued bonus stock grants of 30,000 shares of restricted common stock each to Kyle Tracey, Joseph Andreae, and Allan Viernes. In addition, a total of 60,000 shares were granted to three (3) employees. These issuances were based on the fair market value on the date of issuance immediately vested and resulted in $9,150, $9,150, and $195,200 being charged to cost of revenue, sales and marketing, and general and administrative expense during the three and six months ended March 31, 2015, respectively.



	COMMON STOCK ISSUED FOR SERVICES



	On March 12, 2015, the Company’s Board of Directors issued a bonus stock grant of 60,277 shares of restricted common stock to an outside sales consultant for services performed. This issuance based on the fair market value on the date of issuance immediately vested resulting in $36,769 being charged to sales and marketing expense during the three and six months ended March 31, 2015.



	COMMON STOCK ISSUED FOR ACCRUED WAGES



	On March 12, 2015, Kyle Tracey converted $59,718 of accrued wages into 97,898 shares of immediately vested restricted common stock based on the fair market value on the date of issuance.



	On March 12, 2015, Michael Cook converted $36,769 of accrued wages into 60,277 shares of immediately vested restricted common stock based on the fair market value on the date of issuance.



	COMMON STOCK ISSUED PURSUANT TO DIRECTOR COMPENSATION PLAN



	On March 12, 2015, the Company’s Board of Directors established a Board Compensation Plan that provided for quarterly restricted stock grants to its Board members to compensate them for services provided to the Company. In connection with the establishment of the Board Compensation Plan, 100,000 shares of restricted common stock each were granted to Kyle Tracey and Joseph Andreae for serving on the Board of Directors. See Note 11 regarding Enactment of Corporate Governance Measures for an amendment to the Board Compensation Plan.



WARRANTS



The table below summarizes the Company’s warrant activity during the six month period ended March 31, 2015:



		Shares			Weighted Average Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Warrants outstanding at September 30, 2014			1,184,726		$	0.114		1.6	$	7,217,234
Warrants issued			-			-
Warrants exercised			-			-
Cancelled/forfeited/expired			-			-
Warrants outstanding at March 31, 2015			1,184,726		$	0.114		1.2	$	896,696



The Company’s warrants above are accounted for as derivative liabilities in the accompanying consolidated balance sheets.



OPTIONS



On June 27, 2014, the Company authorized the “2014 Incentive and Nonstatutory Stock Option Plan” (the “Plan”) whereby a maximum of 2,000,000 shares of the Company’s common stock could be granted in the form of incentive and nonstatutory stock options. If any shares of common stock subject to an award under the Plan are forfeited, expire, are settled for cash or are tendered by the participant or withheld by us to satisfy any tax withholding obligation, then, in each case, the shares subject to the award may be used again for awards under the Plan to the extent of the forfeiture, expiration, cash settlement or withholding. The stock option awards issuable under the Plan can be made up of any combination of incentive and nonstatutory stock options. The stock options will be granted at fair market value on the date of grant and will vest as directed by the Board of Directors. Incentive stock options are available to employees only whereas nonstatutory stock options are available to independent contractors and consultants of the Company.



On June 27, 2014, concurrent with the formal adoption of the Plan, the Company’s Board of Directors granted a total of 1,000,000 stock options to certain employees, consultants and/or independent contractors of the Company (the “Option Grant”). The Option Grant includes options to purchase 520,000 shares granted to employees, consultants and/or independent contractors of the Company that are not executive officers. In addition, the Board determined that executive officer Michael Cook, Director of Business Development, should receive options to purchase 100,000 shares and that Kyle Tracey, Chief Executive Officer and Chairman, and Joseph Andreae, President and member of the Board, should receive options to purchase 190,000 shares each. The options were granted at the market price of the Company’s common stock at close of business ($1.66 per share) on June 27, 2014, pursuant to the Company’s standard form stock option agreements under the Plan. The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant. The aggregate value of the 1,000,000 options on the grant date was $1,660,000 and the amount expensed upon the grant date was $415,000 as result of 250,000 options immediately vested. On September 30, 2014 an additional $22,312 was expensed due to the revaluing 212,500 non-employee options.



The description of the incentive and nonstatutory stock options herein is qualified in its entirety by reference to the full text of the Form of Incentive Stock Option Agreement and Nonstatutory Stock Option Agreement, which are attached as Exhibits 10.2 and 10.3, respectively, to the Current Report on Form 8-K filed with the SEC on July 3, 2014.



Additional Option Grants Under 2014 Stock Option Plan



On October 20, 2014, the Company’s Board of Directors granted a total of 20,000 stock options to certain employees and canceled 20,000 options previously allocated (but not issued) to employees. The options were granted at the market price of the Company’s common stock at close of business ($0.83 per share). The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant. The aggregate value of the 20,000 options on the grant date was $16,600 and the amount expensed upon the grant date was $4,150 as result of 5,000 options immediately vested.



On December 22, 2014, the Company’s Board of Directors granted a total of 775,000 stock options to certain employees. The option grant includes options to purchase 225,000 shares granted to employees that are not executive officers. In addition, the Board determined that executive officer Michael Cook, Director of Business Development, should receive options to purchase 25,000 shares and that Kyle Tracey, Chief Executive Officer and Chairman, and Joseph Andreae, President and member of the Board, and Allan Viernes, Chief Financial Officer should receive options to purchase 175,000 shares each. The options were granted at the market price of the Company’s common stock at close of business ($0.70 per share). The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant. The aggregate value of the 775,000 options on the grant date was $542,500 and the amount expensed upon the grant date was $135,625 as result of 193,750 options immediately vested.



Consulting Agreements



On October 20, 2014, the Company entered into consulting agreements with two consultants to provide business development and acquisition services to the Company. The consultants were each issued 100,000 options to purchase common stock of the Company by the Board of Directors as consideration for consulting services. The options were granted at the market price of the Company’s common stock at close of business ($0.83 per share). The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant. The aggregate value of the 200,000 options on the grant date was $166,000 and the amount expensed upon the grant date was $41,500 as result of 50,000 options immediately vested. On December 31, 2014 an additional $3,000 was expensed due to the revaluing the 200,000 non-employee options.



As of March 31, 2015, no options are available for issuance under the Plan. During the year ended September 30, 2014, the Company recorded $537,849 of non-cash “stock options expense” related to the options issued/granted. There was no such expense in the same period during fiscal year 2014.



Option activity during the six months ended March 31, 2015, was as follows:



		Shares			Weighted		Weighted		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual Term
Options outstanding at September 30, 2014			1,150,000		$	2.92		8.7	$	4,648,294
Options granted			995,000		$	0.73		10
Options exercised			-		$	-		-
Options cancelled/forfeited/expired			(145,000	)	$	11.61		9.2
Options outstanding at March 31, 2015			2,000,000		$	1.2		9.7	$	317,629
Options exercisable at March 31, 2015			751,250		$	1.36		9.6	$	79,407



The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the aggregate difference between the closing stock prices of VAPE’s common stock at the specified dates and the exercise prices for in-the-money options) that would have been received by the option holders if all in-the-money options had been exercised on the specified dates.



The fair value of each option award is estimated on the date of grant using the Black-Scholes valuation model, consistent with the provisions of ASC 718. Because option-pricing models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. VAPE has limited relevant historical information to support the expected exercise behavior because no exercises have taken place.



During the six months ended March 31, 2015 and 2014, $466,587 and $0 were recorded as stock-based compensation related to employee options, respectively. During six months ended March 31, 2015 and 2014, $71,262 and $0 were recorded as stock-based compensation related to non-employee options, respectively. As of March 31, 2015, future stock compensation expense related to employee grants for the fiscal years ending September 30, 2015 and 2016 is expected to be $466,587 and $606,362, respectively. As of March 31, 2015, future stock compensation expense related to non-employee grants for the years ending September 30, 2015 and 2016 is expected to be $21,167 and $42,333, respectively.

Intellectual_Property

Intellectual Property	6 Months Ended
Intellectual Property	Mar. 31, 2015
Intellectual Property [Abstract]
INTELLECTUAL PROPERTY	NOTE 9. INTELLECTUAL PROPERTY



	The Company plans to rely on a combination of trademark, copyright, trade secret and patent laws in the United States as well as confidentiality procedures and contractual provisions to protect future proprietary technology and its brands, as they are developed. The Company has begun to execute on this plan with the acquisition of the patent pending HIVE Ceramic vaporization product and the HIVE trademark as well as several pending trademark applications. The Company intends to continue to create or acquire proprietary vaporizers and e-cigarettes, and various trademarks, patents and/or copyrights for brands which are developed.



	TRADEMARKS



	On March 27, 2014, the Company and Stone Arch Studio, LLC entered into a Trademark Assignment Agreement whereby the Company acquired all right, title, priority and interest to the HIVE trademark U.S. Registration No. 44513069 as registered with the U.S. Patent and Trade Office (“USPTO”). This acquisition further protects the Company’s HIVE Ceramics brand vaporization line. In addition, the Company has filed for trademark protection with the USPTO on several additional trademarks and tradenames to be utilized by the Company in the future as the marks register. As of March 31, 2015, the Company has capitalized $123,150 in costs related to the trademarks.



	PATENTS



	On March 27, 2014, the Company formally closed its acquisition of the patent pending HIVE Ceramics vaporization technology. The Company has already begun exploiting this technology and intends to prosecute the patent application to completion. As of March 31, 2015, the Company has capitalized $20,420 in costs related to the pending patents.



	The Company is engaged in developing proprietary rights of the type that may be awarded patents for enhancements to its core HIVE product line as well as proprietary rights in related product lines. The Company also expects that from time to time it is in discussions to acquire additional patented technology from third parties to further grow and develop branded product lines in the vaporization market. Additionally, the Company has recently appointed Mark Scialdone, PhD as its Chief Science Officer to further expand the Company’s patent portfolio in various areas related to the Company’s industry. See Note 11 on Subsequent Events.

Segment_Information

Segment Information	6 Months Ended
Segment Information	Mar. 31, 2015
Segment Information [Abstract]
SEGMENT INFORMATION	NOTE 10. SEGMENT INFORMATION



	The Company reports information about operating segments, as well as disclosures about products and services and major customers. Operating segments are defined as revenue-producing components of the enterprise, which are generally used internally for evaluating segment performance. Management has determined that the corporate, business development, and science consulting operations of VAPE (“VAPE”), HIVE Ceramics and its product lines of HIVE Glass and HIVE Supply (shall be referred to herein collectively as “HIVE”), and Offset’s marketing and merchandising operations (“MARKETING”) should be disclosed separately as management reviews consolidated financial statements for these entities separately and makes decisions independently of the other entities included within the Company’s consolidated financial statements. All intercompany transactions between the reportable segments are eliminated upon consolidation of the Company. As of March 31, 2015, the HIVE and MARKETING segments are the only revenue producing segments of the Company and are based in California.



	The Company evaluates the performance of its segments based on net income (loss) from operations. Certain income and charges are not allocated to segments in the Company’s management reports because they are not considered in evaluating the segments’ operating performance. The following is a summary of information about profit or loss and assets by segment:



	Vape Holdings, Inc.

	Segment Information

	(Unaudited)





		For the Three Months Ended March 31, 2015												For the Six Months Ended March 31, 2015
		VAPE			HIVE			MARKETING			Consolidated			VAPE			HIVE			MARKETING			Consolidated
	Revenue
	Ceramics	$	-		$	396,100		$	-		$	396,100		$	-		$	782,743		$	-		$	782,743
	Merchandise		-			-			19,159			19,159			-			-			19,159			19,159
	Total revenue		-			396,100			19,159			415,259			-			782,743			19,159			801,902

	Cost of revenue
	Ceramics		-			280,828			-			280,828			-			430,714			-			430,714
	Merchandise		-			-			16,814			16,814			-			-			16,814			16,814
	Total cost of revenue		-			280,828			16,814			297,642			-			430,714			16,814			447,528

	Gross profit		-			115,272			2,345			117,617			-			352,029			2,345			354,374

	Operating expense:
	Sales and Marketing		3,777			274,294			17,987			296,058			5,778			341,574			17,987			365,339
	Research and development		-			200			-			200			-			52,053			-			52,053
	General and administrative		246,395			927,426			59,783			398,343			675,671			638,174			59,205			1,373,050
	Total operating expenses		250,173			367,236			77,192			694,601			681,449			1,031,800			77,192			1,790,441

	Operating loss	$	(250,172	)	$	(251,963	)	$	(74,847	)	$	(576,984	)	$	(681,449	)	$	(679,771	)	$	(74,847	)	$	(1,436,067	)

	Other income (expense):
	Interest expense											(93,488	)											(171,478	)
	Interest expense - related party											(6,587	)											(152,150	)
	Change in warrant liability											414,654												1,824,479
	Gain on settlement											367,531												625,461
	Loss on debt modification											(19,981	)											(19,981	)
	Total other income, net											662,129												2,106,331

	Income before provision for income taxes											85,145												670,264

	Provision for income taxes											-												2,209

	Net income										$	85,145											$	668,055



	During the three and six months ended March 31, 2014, all results of operations were attributed to the HIVE segment.

Subsequent_Events

Subsequent Events	6 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS



	Nouveau



	See Note 1 regarding formation of VAPE wholly-owned subsidiary Nouveau.



	$2M Security Purchase Agreement Update



	See Note 5 regarding funding of $361,600 towards the $2M Note.



	Chief Science Officer



	On May 1, 2015, the Company appointed Dr. Mark A. Scialdone to the newly-created executive officer position of Chief Science Officer.



	Dr. Scialdone’s Executive Employment Agreement is for a period of two (2) years. Dr. Scialdone shall receive an annual salary of $102,000, he shall be eligible for any benefits made generally available by the Company, he shall be eligible to receive any bonuses made generally available by the Company, and he shall be reimbursed for any reasonable expenses incurred while performing his duties as the Company’s Chief Science Officer. Additionally, Dr. Scialdone is entitled to receive severance equal to six (6) months base salary if terminated without cause by the Company.



	The Chief Science Officer will also receive bonus compensation associated with revenue generated from consulting services revenues generated over the term of this Agreement such bonus compensation to be calculated in accordance with the schedule below.



	Gross Consulting Revenue* Earned: Industry Related



	Year 1 (from May 1, 2015 through April 30, 2016)



	Up to $200,000 gross revenue		2,5%
	From $200,000—$400,000 gross revenue		5.00%
	From $400,000—$600,000 gross revenue		7.50%
	Above $600,000 gross revenue		10.00%

	Year 2 (from May 1, 2016 through April 30, 2017)

	Up to $200,000 gross revenue		2.50%
	From $200,000—$400,000 gross revenue		5.00%
	From $400,000—$600,000 gross revenue		7.50%
	Above $600,000 gross revenue		10.00%

	Gross Revenue Earned Non Industry Related (including Legacy Business Relationships)

	50/50 share (payable monthly based on actual net revenue collections.



	* Gross Consulting Revenue is defined herein to exclude specific reimbursable vendor costs, travel expenses including airfare.



The Company agrees that in the event that revenue is realized by the Company or one of the Company's wholly owned or partially owned subsidiaries ("VAPE Affiliates"), as applicable, from the exploitation of intellectual property that is developed with Executive as the inventor or co-inventor, then the Company will pay Executive as follows:



	i.	For licenses to parties other than the Company or VAPE Affiliates, fifteen percent (15%) of Net Royalties received by the Company and/or applicable VAPE Affiliate on all such licenses and extensions thereof in perpetuity;

	ii.	For licenses to or other exploitation by the Company or a VAPE Affiliate, 5% of Net Profit received by the Company or applicable VAPE Affiliate from the sales of products incorporating the intellectual property in perpetuity.

	iii.	For purposes this of Subsection 2(d):



	-1	"Net Royalties" shall be calculated by determining gross royalties received and subtracting any unrecouped out-of-pocket costs incurred by the Company and/or applicable VAPE Affiliate for filing, prosecution, licensing and patent defense directly related to the specific rights that are licensed.

	-2	"Net Profit" shall be calculated by determining the net profit received by the Company or applicable VAPE Affiliate from the sales of the product incorporating the invention starting with the gross revenue from sales and subtracting the costs incurred by the Company, and any returns, sales allowances and sales discounts.



Settlement Stock Surrender



On May 11, 2015, newly-appointed COO Benjamin Beaulieu (see below), President Joe Andreae, and CEO Kyle Tracey (the “Officers”) entered into a Stock Surrender Agreement with the Corporation whereby the Officers have agreed to surrender all legal right, title and interest in an aggregate of 440,625 shares of common stock of the Corporation to the Corporation. The shares were originally assigned to the Officers pursuant to a settlement by and between the Corporation and certain shareholders and related parties. See Note 7 regarding Settlement of Legal Claims. The shares were retained by the Corporation and will be designated as treasury stock.



A copy of the Stock Surrender Agreement is attached as Exhibit 10.1 to this Quarterly Report on Form 10-Q and is incorporated by reference herein.



Surrender of Stock Options



Collectively, officers, employees, and consultants of the Company decided to surrender 1,000,000 options to purchase the Company’s common stock granted from the 2014 Plan for the purpose of making options available for future strategic grants. The Chief Executive Officer, President, and Chief Operating Officer decided to forfeit 190,000 incentive statutory options each with an exercise price of $1.66. The former Business Development Officer decided to forfeit 100,000 incentive statutory options with an exercise price of $1.66. Three employees of the Company collectively decided to forfeit 117,500 incentive statutory options with an exercise price of $1.66. Consultants of the Company collectively decided to forfeit 217,500 incentive statutory options for benefit of the Company with an exercise price of $1.66. The Company cancelled these options on May 11, 2015.



A copy of the Form Option Surrender Agreement is attached as Exhibit 10.2 to this Quarterly Report on Form 10-Q and is incorporated by reference herein.



Officer & Director Appointments and Related Matters



Pursuant to Board consent on May 11, 2015, the Company made several changes to its management structure.



The Company confirmed the appointment of Dr. Mark Scialdone to the newly-created officer position of Chief Science Officer which was announced by Current Report on Form 8-K dated May 5, 2015 which is incorporated by reference herein. See above in this section for more information about Dr. Scialdone.



The Company also appointed Benjamin Beaulieu, the Corporation’s current Operations Manager, to the newly-created officer position of Chief Operating Officer.



Benjamin Beaulieu, 29, delivers valued experience in the implementation and integration of operational and sales systems to the VAPE Holdings executive team.



Mr. Beaulieu has owned operated several multi-million-dollar retail garden supply and technology businesses. With a focus on automation and functionality, Mr. Beaulieu has successfully expanded those companies from brick and mortar locations to E-commerce superstores with global sales and partnerships with the industry’s top distributors in the United States and Canada. Mr. Beaulieu’s experience operating various companies in the ancillary MMJ markets has already improved Hive Ceramics and VAPE Holdings employee management and development. With a focus on streamlining operations Mr. Beaulieu will allow Vape Holdings, Inc. and subsidiaries to rapidly grow while combating the associated costs responsibly.



The Company also decided to refocus Michael Cook, the Company's Director of Business Development, to the role of HIVE Sales and Product Development Manager in order to more effectively utilize his industry connections and streamline his involvement with product design and aggressively drive the sales department to market its various segments, such as HIVE Ceramics, HIVE Supply, and HIVE Glass. Mr. Cook’s position will report to the newly appointed Chief Operating Officer. The Company has determined that Mr. Cook’s new position will no longer result in him being considered an “Executive Officer” under the SEC’s rules and regulations. Mr. Cook was never formally appointed as an officer of the Company, but was previously determined to qualify as an executive officer under SEC rules and regulations.



In addition to the officer appointments and changes above, the Board of Directors of the Company formally appointed current CFO Allan Viernes and newly-appointed COO Benjamin Beaulieu as new members of the Board of Directors. Messrs. Viernes and Beaulieu will join CEO Kyle Tracey and President Joe Andreae on the four-person board. In connection with the appointments of Messrs. Viernes and Beaulieu to the Board of Directors, the Company increased its Board size to seven (7) members. Messrs. Viernes and Beaulieu have contributed substantially to the existing operations of the company as well as the successful launch and day-to-day oversight of new business segments.



Messrs. Viernes and Beaulieu have existing employment agreements with the Company. No changes have been made to their existing compensation at this time.



Enactment of Corporate Governance Measures



Also on May 11, 2015, the Board of Directors reaffirmed its commitment to good corporate governance and the related disciplines of organizational excellence and enhanced transparency by commencing several new organizational initiatives. The Board believes that it is now at the proper stage in its development to support this expanded organizational structure to accelerate the Company’s future growth.



Following the increase of the Board size to seven (7) members (as set forth above), the Board determined that it would take steps to fill the currently vacant positions on the Board by identifying and appointing three seasoned independent directors with a mix of finance and business, legal, applied sciences credentials and experience. The Company is searching for qualified candidates and will announce appointments as they occur. VAPE management believes the Company and its shareholders will benefit greatly from the expansion of the Company’s leadership team with the addition of new, independent directors with dynamic and diverse visions and areas of expertise.



In order to properly attract the requisite Board talent, the Company previously approved a Board Compensation Plan on March 12, 2015. On May 11, 2015, the Board amended the terms of the Board Compensation Plan. Pursuant to the amended terms of the Board Compensation Plan, the Board shall issue to outside directors only, a total of 100,000 shares of restricted common stock of the Company per fiscal year of service which shares vest quarterly (i.e. 25,000 shares per quarter).



The Company intends to further support its existing management team with the establishment of an advisory board (the “Advisory Board”) which will consist of a wide array of outside industry experts presenting different viewpoints and areas of expertise to support the growth of existing management and the Companies expansion of new and existing business segments.



In addition, the Board of Directors has authorized the creation of Audit and Compensation Committees (the “Audit Committee” and “Compensation Committee), a Company Code of Ethics, and an Insider Trading Policy to voluntarily meet advanced corporate governance guidelines. Appointments to these committees and the Advisory Board will be announced when available.



Copies of the Audit Committee Charter (Ex. 99.1), Compensation Committee Charter (Ex. 99.2), Code of Ethics (Ex. 14.1) and Insider Trading Policy (Ex. 99.3) are attached as exhibits to this Quarterly Report on Form 10-Q and are incorporated by reference herein.

Accounting_Policies_and_Basis_1

Accounting Policies and Basis of Presentation (Policies)	6 Months Ended
Accounting Policies and Basis of Presentation (Policies)	Mar. 31, 2015
Accounting Policies and Basis of Presentation [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION



	The accompanying unaudited interim consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in the annual financial statements prepared in accordance with the accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these consolidated financial statements have been included. Such adjustments consist of normal recurring adjustments. The current results are not an indication of the full year.
CONSOLIDATION	CONSOLIDATION



	The consolidated financial statements include the assets, liabilities, and operating results of the Company and its wholly-owned subsidiaries, HIVE and Offset after elimination of all material inter-company accounts and transactions.
USE OF ESTIMATES	USE OF ESTIMATES



	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include losses for warrant contingencies and the valuation of conversion features in notes.
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS



	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants as of the measurement date. Applicable accounting guidance provides an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors that market participants would use in valuing the asset or liability. There are three levels of inputs that may be used to measure fair value:



		Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
		Level 2 - Include other inputs that are directly or indirectly observable in the marketplace.
		Level 3 - Unobservable inputs which are supported by little or no market activity.



	The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Derivative instruments include the warrant liability (Level 2). Derivative instruments are valued using standard calculations/models that are primarily based on observable inputs, including volatilities and interest rates. Therefore, derivative instruments are included in Level 2.



	Fair-value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2015 and September 30, 2014. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses, accounts payable, accrued liabilities, and notes payable. Fair values for these items were assumed to approximate carrying values because of their short-term nature or they are payable on demand.



	The following table presents the Company’s fair value hierarchy for assets measured at fair value on a recurring basis at March 31, 2015:



			Level 1		Level 2		Level 3		Total
	Assets
	Cash and cash equivalents		$	241,691	$	-	$	-	$	241,691
	Total assets measured at fair value		$	241,691	$	-	$	-	$	241,691

	Liabilities
	Derivative instruments		$	-	$	639,753	$	-	$	639,753
	Total liabilities measured at fair value		$	-	$	639,753	$	-	$	639,753



	The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at September 30, 2014:



			Level 1		Level 2		Level 3		Total
	Assets
	Cash and cash equivalents		$	48,370	$	-	$	-	$	48,370
	Total assets measured at fair value		$	48,370	$	-	$	-	$	48,370

	Liabilities
	Derivative instruments		$	-	$	2,464,232	$	-	$	2,464,232
	Total liabilities measured at fair value		$	-	$	2,464,232	$	-	$	2,464,232


CONCENTRATION	CONCENTRATION



	Credit Risk



	At times, the Company maintains cash balances at a financial institution in excess of the FDIC insurance limit. In addition, at we extend credit to customers in the normal course of business, after we evaluate the credit worthiness. The Company does not expect to take any unnecessary credit risks causing significant write-offs of potentially uncollectible accounts.



	Supplier



	Two (2) suppliers and one (1) supplier accounted for 79% and 70% of our purchases during the three and six months ended March 31, 2015. The loss of these suppliers would have a significant impact on the Company’s financial results.

REVENUE RECOGNITION	REVENUE RECOGNITION



	The Company recognizes revenues from product sales when (a) persuasive evidence that an agreement exists; (b) the products have been delivered; (c) the prices are fixed and determinable and not subject to refund or adjustment; and (d) collection of the amounts due is reasonably assured. Revenue is recorded when sales orders are shipped.
INVENTORY	INVENTORY



	Inventory is valued at the lower of cost or market, as determined primarily by the average cost inventory method, and are stated using the first-in, first-out (FIFO) method. Management will record a provision for loss for obsolete or slow moving inventory to reduce carrying amounts to net realizable value.



	We purchase product sourced from China which we are required to pay 50% upon placing the order. Amounts paid for products, which have not been received, are recorded as prepaid inventory. There are no amounts paid which are in dispute or considered impaired.
FIXED ASSETS	FIXED ASSETS



	Fixed assets are recorded at cost and depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The estimated life of tooling related to our ceramic products is three (3) years. The estimated life of our leasehold improvements is the lesser of the term of the related lease and useful life.
IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS	IMPAIRMENT OF LONG-LIVED AND PURCHASED INTANGIBLE ASSETS



	The Company has adopted Accounting Standards Codification (“ASC”) 350 “Intangibles - Goodwill and Other.” The Statement requires that long-lived assets and certain identifiable intangibles held and used by the Company be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undercounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset. ASC 350 also requires assets to be disposed of be reported at the lower of the carrying amount or the fair value less costs to sell.



	Long-lived assets, such as fixed assets and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management's best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. During the three and six months ended March 31, 2015 and 2014, the Company did not record any impairment of its trademarks and pending patents as its expected future cash flows are in excess of their carrying amounts.
RESEARCH AND DEVELOPMENT	RESEARCH AND DEVELOPMENT



	Research and development costs are expensed as incurred. The costs of materials and equipment that will be acquired or constructed for research and development activities, and that have alternative future uses, both in research and development, marketing or sales, will be classified as fixed assets and depreciated over their estimated useful lives. To date, research and development costs include the research and development expenses related to prototypes of the Company’s products. During the six months ended March 31, 2015 and 2014, research and development costs were $52,053 and $37,587, respectively.
CONVERTIBLE DEBT	CONVERTIBLE DEBT



	Convertible debt is accounted for under the guidelines established by ASC 470-20 “Debt with Conversion and Other Options”. ASC 470-20 governs the calculation of an embedded beneficial conversion, which is treated as an additional discount to the instruments where derivative accounting (explained below) does not apply. The amount of the value of warrants and beneficial conversion feature may reduce the carrying value of the instrument to zero, but no further. The discounts relating to the initial recording of the derivatives or beneficial conversion features are accreted over the term of the debt. Many of the conversion features embedded in the Company's convertible notes are variable and are adjusted based on a discount to market prices which could cause an unlimited number of common stock to be issued. The management and board of directors currently have the ability to authorize additional shares of common stock primarily through their super voting rights under the Series A Preferred stock (See “NOTE 8 - STOCKHOLDERS’ DEFICIT”).



	When applicable, the Company calculates the fair value of warrants and conversion features issued with the convertible instruments using the Black-Scholes valuation method, using the same assumptions used for valuing employee options for purposes of ASC 718 “Compensation - Stock Compensation”, except that the contractual life of the warrant or conversion feature is used. Under these guidelines, the Company allocates the value of the proceeds received from a convertible debt transaction between the conversion feature and any other detachable instruments (such as warrants) on a relative fair value basis. The allocated fair value is recorded as a debt discount or premium and is amortized over the expected term of the convertible debt to interest expense. If the fair value exceeds the carrying value of the debt, an immediate charge to operations is recorded by management. Each reporting period, the Company will compute the estimated fair value of derivatives and record changes to operations. Currently no instruments are being recorded as such.



	The Company accounts for modifications of its BCF’s in accordance with ASC 470-50 “Modifications and Extinguishments.” ASC 470-50 requires the modification of a convertible debt instrument that changes the fair value of an embedded conversion feature and the subsequent recognition of interest expense or the associated debt instrument when the modification does not result in a debt extinguishment.
DERIVATIVE FINANCIAL INSTRUMENTS	DERIVATIVE FINANCIAL INSTRUMENTS



	Derivative financial instruments, as defined in ASC 815, “Accounting for Derivative Financial Instruments and Hedging Activities”, consist of financial instruments or other contracts that contain a notional amount and one or more underlying (e.g. interest rate, security price or other variable), require no initial net investment and permit net settlement. Derivative financial instruments may be free-standing or embedded in other financial instruments. Further, derivative financial instruments are initially, and subsequently, measured at fair value and recorded as liabilities or, in rare instances, assets.



	The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has issued financial instruments including senior convertible notes payable and freestanding stock purchase warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by ASC 815, in certain instances, these instruments are required to be carried as derivative liabilities, at fair value, in our consolidated financial statements.



	The Company estimates the fair values of derivative financial instruments using various techniques (and combinations thereof) that are considered to be consistent with objectively measuring fair values. In selecting the appropriate technique, consideration is given to, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For less complex derivative instruments, such as free-standing warrants, the Company generally uses the Black-Scholes option valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the trading market price of our common stock, which has a high-historical volatility. Since derivative financial instruments are initially and subsequently carried at fair values, the Company's operating results will reflect the volatility in these estimate and assumption changes.
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE



	Basic earnings per common share is computed by dividing net income available to common shareholders by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing net income available to common shareholders by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans and the weighted-average number of common shares outstanding during the reporting period. Dilutive common share equivalents include the dilutive effect of in-the-money share equivalents, which are calculated, based on the average share price for each period using the treasury stock method. Under the treasury stock method, the exercise price of an award, if any, the amount of compensation cost, if any, for future service that the Company has not yet recognized, and the estimated tax benefits that would be recorded in paid-in capital, if any, when an award is settled are assumed to be used to repurchase shares in the current period.



	The following is a summary of outstanding securities which have been included in the calculation of diluted net income per share and reconciliation of net income to net income available to common stock holders:



			For the Three Months Ended		For the Six Months Ended
				31-Mar-15		31-Mar-15
	Weighted average common shares outstanding used in calculating basic earnings per share			11,148,666		10,918,103
	Effect of preferred stock			500,000		500,000
	Effect of convertible notes payable			2,025,679		2,025,679
	Effect of options and warrants			197,143		161,264
	Weighted average common and common equivalent shares used in calculating diluted earnings per share			13,871,488		13,605,046

	Net income as reported		$	85,145	$	668,055
	Add - interest on convertible notes payable			100,075		323,506
	Net income available to common stockholders		$	185,220	$	991,561



	The Company excluded 751,250 and 502,500 options from the computation for the three and six months ended March 31, 2015, as their exercise prices were in excess of the average closing market price of the Company’s common stock, causing their effects to be anti-dilutive using the treasury stock method.



	During the three and six months ended March 31, 2014, 642,346 convertible note shares would have been included in the computation of dilutive shares outstanding since the exercise prices did not exceed the average market value of the Company's common stock if the Company generated net income. During the three and six months ended March 31, 2014, no options and warrants would have been included had the Company generated net income in the computation of dilutive shares outstanding using the treasury-stock method since the exercise prices exceeded the average market value of the Company's common stock.
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION



	ASC 718, “Share-Based Payment” requires that compensation cost related to share-based payment transactions be recognized in the consolidated financial statements. Share-based payment transactions within the scope of ASC 718 include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans.



	The Company adopted ASC 718, which requires disclosure of the fair value and other characteristics of stock options and more prominent disclosure about the effects of an entity’s accounting policy decisions with respect to stock-based compensation on reported net loss. The Company has reflected the expense of such stock based compensation based on the fair value at the grant date for awards consistent with the provisions of ASC 718.



	In connection with the adoption of ASC 718, the fair value of our share-based compensation has been determined utilizing the Black-Scholes pricing model. The fair value of the options granted is amortized as compensation expense on a straight line basis over the requisite service period of the award, which is generally the vesting period. The fair value calculations involve significant judgments, assumptions, estimates and complexities that impact the amount of compensation expense to be recorded in current and future periods. Upon option exercise, the Company issues new shares of stock.



	The following weighted average variables were used in the Black Scholes model for all option issuances valued during the six months ended March 31, 2015 and 2014:



	Six Months		Stock Price at		Dividend		Exercise		Risk Free			Volatility			Average
	Ended		Grant Date		Yield		Price		Interest Rate						Life
	March 31,
	2015		$	0.73		-%	$	0.73		2.2	%		380	%		10
	2014			n/a		n/a		n/a		n/a			n/a			n/a



	The Company's accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services follows the provisions of Emerging Issues Task Force (“EITF”) 96-18, “Accounting for Equity Instruments That are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services”, codified into ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS



	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers”, which supersedes most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for these goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. This guidance is effective for the Company in the first quarter of fiscal year 2018 and early application is not permitted. Entities must adopt the new guidance using one of two retrospective application methods. The Company is currently evaluating the standard but does not expect it to have a material impact on our financial position, results of operations or cash flows.



	The Financial Accounting Standards Board issues Accounting Standard Updates (“ASUs”) to amend the authoritative literature in Accounting Standards Codification (“ASC”). There have been a number of ASUs to date that amend the original text of ASC. The Company believes those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to the Company or (iv) are not expected to have a significant impact on the Company.
RISKS AND UNCERTAINTIES	RISKS AND UNCERTAINTIES



	Although forward-looking statements in this Quarterly Report reflect our good faith judgment, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include without limitation those discussed under the heading “Risk Factors” below, as well as those discussed elsewhere in this Quarterly Report. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report. Readers are urged to carefully review and consider the various disclosures made in this Quarterly Report, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Accounting_Policies_and_Basis_2

Accounting Policies and Basis of Presentation (Tables)	6 Months Ended
Accounting Policies and Basis of Presentation (Tables)	Mar. 31, 2015
Accounting Policies and Basis of Presentation [Abstract]
Schedule of assets and liabilities measured at fair value on a recurring basis		Level 1		Level 2		Level 3		Total
	Assets
	Cash and cash equivalents	$	241,691	$	-	$	-	$	241,691
	Total assets measured at fair value	$	241,691	$	-	$	-	$	241,691

	Liabilities
	Derivative instruments	$	-	$	639,753	$	-	$	639,753
	Total liabilities measured at fair value	$	-	$	639,753	$	-	$	639,753



		Level 1		Level 2		Level 3		Total
	Assets
	Cash and cash equivalents	$	48,370	$	-	$	-	$	48,370
	Total assets measured at fair value	$	48,370	$	-	$	-	$	48,370

	Liabilities
	Derivative instruments	$	-	$	2,464,232	$	-	$	2,464,232
	Total liabilities measured at fair value	$	-	$	2,464,232	$	-	$	2,464,232
Schedule of reconciliation of net income available to common stock holders		For the Three Months Ended		For the Six Months Ended
			31-Mar-15		31-Mar-15
	Weighted average common shares outstanding used in calculating basic earnings per share		11,148,666		10,918,103
	Effect of preferred stock		500,000		500,000
	Effect of convertible notes payable		2,025,679		2,025,679
	Effect of options and warrants		197,143		161,264
	Weighted average common and common equivalent shares used in calculating diluted earnings per share		13,871,488		13,605,046

	Net income as reported	$	85,145	$	668,055
	Add - interest on convertible notes payable		100,075		323,506
	Net income available to common stockholders	$	185,220	$	991,561
Summary of weighted average variables used in the Black Scholes model	Six Months	Stock Price at		Dividend		Exercise		Risk Free			Volatility			Average
	Ended	Grant Date		Yield		Price		Interest Rate						Life
	March 31,
	2015	$	0.73		-%	$	0.73		2.2	%		380	%		10
	2014		n/a		n/a		n/a		n/a			n/a			n/a

Fixed_Assets_Tables

Fixed Assets (Tables)	6 Months Ended
Fixed Assets (Tables)	Mar. 31, 2015
Fixed Assets [Abstract]
Summary of fixed assets		March 31,			September 30,
		2015			2014
	Molds and Tooling	$	135,505		$	122,555
	Leasehold improvements		29,795			-
	Accumulated depreciation		(45,992	)		(16,178	)
		$	119,308		$	106,377

Accrued_Expenses_Tables

Accrued Expenses (Tables)	6 Months Ended
Accrued Expenses (Tables)	Mar. 31, 2015
Accrued Expenses [Abstract]
Summary of accrued expenses

		March 31, 2015		September 30,
		March 31, 2015		2014
	Accrued interest	$	22,841	$	16,300
	Accrued interest - related party		16,460		18,325
	Accrued wages and taxes		27,779		108,374
	Other		17,727		26,514
		$	84,807	$	169,513

Stockholders_Deficit_Tables

Stockholders' Deficit (Tables)	6 Months Ended
Stockholders' Deficit (Tables)	Mar. 31, 2015
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option activity		Shares			Weighted		Weighted		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual Term
	Options outstanding at September 30, 2014		1,150,000		$	2.92		8.7	$	4,648,294
	Options granted		995,000		$	0.73		10
	Options exercised		-		$	-		-
	Options cancelled/forfeited/expired		(145,000	)	$	11.61		9.2
	Options outstanding at March 31, 2015		2,000,000		$	1.2		9.7	$	317,629
	Options exercisable at March 31, 2015		751,250		$	1.36		9.6	$	79,407
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of option activity		Shares			Weighted Average Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
	Warrants outstanding at September 30, 2014		1,184,726		$	0.114		1.6	$	7,217,234
	Warrants issued		-			-
	Warrants exercised		-			-
	Cancelled/forfeited/expired		-			-
	Warrants outstanding at March 31, 2015		1,184,726		$	0.114		1.2	$	896,696

Segment_Information_Tables

Segment Information (Tables)	6 Months Ended
Segment Information (Tables)	Mar. 31, 2015
Segment Information [Abstract]
Schedule of segment reporting information	Vape Holdings, Inc.

	Segment Information

	(Unaudited)





		For the Three Months Ended March 31, 2015												For the Six Months Ended March 31, 2015
		VAPE			HIVE			MARKETING			Consolidated			VAPE			HIVE			MARKETING			Consolidated
	Revenue
	Ceramics	$	-		$	396,100		$	-		$	396,100		$	-		$	782,743		$	-		$	782,743
	Merchandise		-			-			19,159			19,159			-			-			19,159			19,159
	Total revenue		-			396,100			19,159			415,259			-			782,743			19,159			801,902

	Cost of revenue
	Ceramics		-			280,828			-			280,828			-			430,714			-			430,714
	Merchandise		-			-			16,814			16,814			-			-			16,814			16,814
	Total cost of revenue		-			280,828			16,814			297,642			-			430,714			16,814			447,528

	Gross profit		-			115,272			2,345			117,617			-			352,029			2,345			354,374

	Operating expense:
	Sales and Marketing		3,777			274,294			17,987			296,058			5,778			341,574			17,987			365,339
	Research and development		-			200			-			200			-			52,053			-			52,053
	General and administrative		246,395			927,426			59,783			398,343			675,671			638,174			59,205			1,373,050
	Total operating expenses		250,173			367,236			77,192			694,601			681,449			1,031,800			77,192			1,790,441

	Operating loss	$	(250,172	)	$	(251,963	)	$	(74,847	)	$	(576,984	)	$	(681,449	)	$	(679,771	)	$	(74,847	)	$	(1,436,067	)

	Other income (expense):
	Interest expense											(93,488	)											(171,478	)
	Interest expense - related party											(6,587	)											(152,150	)
	Change in warrant liability											414,654												1,824,479
	Gain on settlement											367,531												625,461
	Loss on debt modification											(19,981	)											(19,981	)
	Total other income, net											662,129												2,106,331

	Income before provision for income taxes											85,145												670,264

	Provision for income taxes											-												2,209

	Net income										$	85,145											$	668,055

Subsequent_Events_Tables

Subsequent Events (Tables)	6 Months Ended
Subsequent Events (Tables)	Mar. 31, 2015
Description of Business and Summary of Significant Accounting Policies [Abstract]
Schedule of gross consulting revenue	Year 1 (from May 1, 2015 through April 30, 2016)



	Up to $200,000 gross revenue	2,5%
	From $200,000—$400,000 gross revenue	5.00%
	From $400,000—$600,000 gross revenue	7.50%
	Above $600,000 gross revenue	10.00%

	Year 2 (from May 1, 2016 through April 30, 2017)

	Up to $200,000 gross revenue	2.50%
	From $200,000—$400,000 gross revenue	5.00%
	From $400,000—$600,000 gross revenue	7.50%
	Above $600,000 gross revenue	10.00%

Description_of_Business_and_Su1

Description of Business and Summary of Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Sep. 30, 2014	Sep. 30, 2013
Description of Business and Summary of Significant Accounting Policies [Textual ]
Cash	$241,691	$598,953	$241,691	$598,953	$48,370	$568
Working capital deficit			17,858
Loss from operations	($576,984)	($215,800)	($1,436,067)	($434,619)

Accounting_Policies_and_Basis_3

Accounting Policies and Basis of Presentation (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Mar. 31, 2015	Sep. 30, 2014
Assets
Cash and cash equivalents	$241,691	$48,370
Total assets measured at fair value	241,691	48,370
Liabilities
Derivative instruments	639,753	2,464,232
Total liabilities measured at fair value	639,753	2,464,232
Level 1 [Member]
Assets
Cash and cash equivalents	241,691	48,370
Total assets measured at fair value	241,691	48,370
Liabilities
Derivative instruments
Total liabilities measured at fair value
Level 2 [Member]
Assets
Cash and cash equivalents
Total assets measured at fair value
Liabilities
Derivative instruments	639,753	2,464,232
Total liabilities measured at fair value	639,753	2,464,232
Level 3 [Member]
Assets
Cash and cash equivalents
Total assets measured at fair value
Liabilities
Derivative instruments
Total liabilities measured at fair value

Accounting_Policies_and_Basis_4

Accounting Policies and Basis of Presentation (Details 1) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Accounting Policies and Basis of Presentation [Abstract]
Weighted average common shares outstanding used in calculating basic earnings per share	11,148,666		10,918,103
Effect of preferred stock	500,000		500,000
Effect of convertible notes payable	2,025,679		2,025,679
Effect of options and warrants	197,143		161,264
Weighted average common and common equivalent shares used in calculating diluted earnings per share	13,871,488	6,278,464	13,605,046	6,415,512
Net income as reported	$85,145	($29,805,364)	$668,055	($30,072,691)
Add - Interest on convertible notes payable	100,075		323,506
Net income available to common stockholders	$185,220		$991,561

Accounting_Policies_and_Basis_5

Accounting Policies and Basis of Presentation (Details 2) (USD $)	6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Weighted average variables used in the Black Scholes model
Stock Price at Grant Date	$0.73
Dividend Yield
Exercise Price	$0.73
Risk Free Interest Rate	2.20%
Volatility	380.00%
Average Life	10 years

Accounting_Policies_and_Basis_6

Accounting Policies and Basis of Presentation (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
	supplier	Mar. 31, 2014	supplier	Mar. 31, 2014
Description of Business And Summary of Significant Accounting Policies (Textual)
Number of suppliers	1		2
Credit risk rate	79.00%		70.00%
Purchase interest rate			50.00%
Estimated useful lives			3 years
Research and development expense	$200	$29,087	$52,053	$37,587
Number of options excluded from the compution of diluted shares outstanding	751,250	642,346	502,500	642,346

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	Mar. 31, 2015	Sep. 30, 2014
Fixed Assets [Abstract]
Molds and Tooling	$135,505	$122,555
Leasehold improvements	29,795
Accumulated depreciation	-45,992	-16,178
Fixed assets, net	$119,308	$106,377

Fixed_Assets_Details_Textual

Fixed Assets (Details Textual) (USD $)	6 Months Ended
Fixed Assets (Details Textual) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Fixed Assets [Abstract]
Depreciation	$29,815

Accrued_Expenses_Details

Accrued Expenses (Details) (USD $)	Mar. 31, 2015	Sep. 30, 2014
Summary of Accrued Expenses:
Accrued interest	$22,841	$16,300
Accrued interest - related party	16,460	18,325
Accrued wages and taxes	27,779	108,374
Other	17,727	26,514
Accrued expenses	$84,807	$169,513

Third_Party_Debt_Details

Third Party Debt (Details) (USD $)	3 Months Ended		6 Months Ended		0 Months Ended						1 Months Ended	3 Months Ended	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Dec. 03, 2014	Feb. 10, 2015	Mar. 12, 2015	Feb. 11, 2014	Oct. 28, 2014	Mar. 19, 2014	Feb. 18, 2014	Jun. 30, 2014	Jun. 30, 2014	Dec. 03, 2014	Sep. 30, 2014
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Dec. 03, 2014	Feb. 10, 2015	Mar. 12, 2015	investors	Oct. 28, 2014	Mar. 19, 2014	Feb. 18, 2014	Jun. 30, 2014	Jun. 30, 2014	Dec. 03, 2014	Sep. 30, 2014
Third Party Debt (Textual)
Principal amount														$500,000
Original issue discount	400,000		400,000
Interest Expense	93,488	51,659	171,478	51,659
Deferred financing costs	39,394		39,394
Deferred financing costs, long-term	5,105		5,105
Net proceeds				242,593
Convertible notes payable, long-term	69,110		69,110												178,200
Convertible notes payable, current	640,383		640,383												187,667
Unamortized discount convertible notes payable, current	256,285		256,285												32,333
Unamortized discount convertible notes payable, non current	24,222		24,222												19,800
Securities Purchase Agreement [Member]
Third Party Debt (Textual)
Principal amount														560,000
Amortized discount to interest expense	8,333		11,111
Original issue discount														50,000
Transaction expenses					10,000
Finder's fee														25,000
Deferred financing costs	45,940		45,940
Net proceeds					475,000
Amortization of interest expense	7,657		10,209
$2M Securities Purchase Agreement [Member]
Third Party Debt (Textual)
Principal amount	2,000,000		2,000,000			2,000,000
Interest rate	10.00%		10.00%
Conversion price	$0.50		$0.50
Discount related to beneficial conversion feature			168,000
Original issue discount	38,400		38,400			182,000
Convertible Notes payable						1,808,000
Accrued and unpaid interest	4,389		4,389
Transaction expenses						10,000
Net proceeds			361,600
Amortization of interest expense	3,200		3,600
Unamortized discount convertible notes payable, current	106,444		106,444
Total unamortized discounts	293,556		293,556
Percentage of premium amount			25.00%
Percentage of conversion price			70.00%
Subsequent funding			361,600
6% Convertible Notes [Member]
Third Party Debt (Textual)
Principal amount								230,000
Interest rate	6.00%		6.00%					6.00%
Amortized discount to interest expense	11,235		33,235
Discount related to beneficial conversion feature								92,000
Convertible Notes payable							17,200
Accrued and unpaid interest							6,000
Number of accredited investors								10
Conversion description								The conversion price of these 6% Notes is the average of the fifteen (15) lowest daily VWAP's occurring during the twenty (20) consecutive trading days immediately preceding the date each Holder elects convert all of their 6% Note minus a discount of 40%.
Percentage of note outstanding							6.00%
Fair value of loss on debt							23,443
Converted Amount							80,000
Converted shares							40,000
6% Convertible Notes [Member] \| Securities Purchase Agreement [Member]
Third Party Debt (Textual)
Deferred financing costs	30,627		30,627
Deferred financing costs, long-term	5,104		5,104
6% Convertible Notes [Member] \| Minimum [Member]
Third Party Debt (Textual)
Maturity date								28-Feb-15
Conversion price							$0.50	$1
6% Convertible Notes [Member] \| Maximum [Member]
Third Party Debt (Textual)
Maturity date								31-Mar-15
Conversion price							$1	$3
10% Convertible Notes [Member] \| Securities Purchase Agreement [Member]
Third Party Debt (Textual)
Interest rate														10.00%
Conversion price														$0.50
Amortized discount to interest expense	28,000		37,333
Discount related to beneficial conversion feature					168,000
Accrued and unpaid interest			18,356
Conversion description					The Note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at a conversion price per share of 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable Conversion (subject to adjustment in the event of stock splits, stock dividends, and similar transactions, and in the event of subsequent sales of common stock at a lower purchase price (subject to certain exceptions))(the "Conversion Price"). In no event will the Conversion Price be less than $0.50 per share.
Repayment of debt description					Repayment of principal on the Note, together with accrued interest thereon, is due in twelve monthly installments, commencing six months from issuance. The Company may make such payments in cash (in which event the Company will pay a 25% premium) or, subject to certain conditions, in shares of common stock valued at the lower of the Conversion Price or 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable payment date.
Convertible notes payable, long-term	69,111		69,111
Convertible notes payable, current	321,333		321,333
Unamortized discount convertible notes payable, current	145,333		145,333
Unamortized discount convertible notes payable, non current	24,222		24,222
8% Convertible Note [Member]
Third Party Debt (Textual)
Principal amount										198,000	20,000
Maturity date										19-Nov-14	18-Feb-16
Interest rate										8.00%	8.00%
Conversion price									$1		$0.50
Amortized discount to interest expense												1,000	1,667
Discount related to beneficial conversion feature										158,400	8,000
Original issue discount											5,333
Convertible Notes payable									198,000	198,000
Accrued and unpaid interest									9,764		1,100
Conversion description										The conversion price for the W-net Note is eighty percent (80%) of the average of the three (3) lowest daily closing bid prices (the 3 lowest prices will be calculated on a VWAP basis) occurring during the ten (10) consecutive Trading Days immediately preceding the applicable conversion date on which the holder elects to convert.	The conversion price for the notes was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Unamortized discount convertible notes payable, non current									$19,800
Converted shares									207,764		42,370
8% Convertible Note [Member] \| Minimum [Member]
Third Party Debt (Textual)
Conversion price										$1
8% Convertible Note [Member] \| Maximum [Member]
Third Party Debt (Textual)
Conversion price										$3

Related_Party_Debt_Details

Related Party Debt (Details) (USD $)	3 Months Ended		6 Months Ended		0 Months Ended			1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended	0 Months Ended
Related Party Debt (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Feb. 28, 2014	Oct. 28, 2014	Mar. 19, 2014	Feb. 18, 2014	Jun. 30, 2014	Jun. 30, 2014	Sep. 30, 2014	12-May-14	Dec. 04, 2014	Aug. 11, 2014	12-May-14	Mar. 17, 2014	Dec. 07, 2013	Dec. 03, 2014	Dec. 31, 2014	Sep. 30, 2013	Jan. 22, 2015	Feb. 11, 2014
Related Party Debt (Textual)
Unamortized discount convertible notes payable, non current	$24,222		$24,222								19,800
Notes payable, related parties	265,000		265,000								341,290
Accrued interest	22,841		22,841								16,300
Interest expense	93,488	51,659	171,478	51,659
Principal amount																		500,000
Unamortized discount	400,000		400,000
Gain on extinguishment of debt			625,461
Hive Asset Acquisition [Member]
Related Party Debt (Textual)
Interest rate					6.00%
Accrued interest	15,270		15,270
Maturity date					27-Feb-16
Interest expense related to notes payable	3,751		7,585
Principal amount					250,000
8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate							8.00%	8.00%
Unamortized discount convertible notes payable, non current						19,800
Accounts payable, related parties								20,000
Maturity date							19-Nov-14	18-Feb-16
Principal amount							198,000	20,000
Conversion price						$1		$0.50
Unamortized discount								5,333
Common stock issued on conversion						207,764		42,370
Discount related to beneficial conversion feature							158,400	8,000
Amortized discount to interest expense									1,000	1,667
Conversion description							The conversion price for the W-net Note is eighty percent (80%) of the average of the three (3) lowest daily closing bid prices (the 3 lowest prices will be calculated on a VWAP basis) occurring during the ten (10) consecutive Trading Days immediately preceding the applicable conversion date on which the holder elects to convert.	The conversion price for the notes was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Accrued and unpaid interest						9,764		1,100
Subsequent Event [Member]
Related Party Debt (Textual)
Interest rate											70.00%
Principal amount																		560,000
Conversion description											The Note bears interest at the rate of 10% per annum and is convertible into common stock of the Company at a conversion price per share of 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable Conversion (subject to adjustment in the event of stock splits, stock dividends, and similar transactions, and in the event of subsequent sales of common stock at a lower purchase price (subject to certain exceptions))(the “Conversion Price”). In no event will the Conversion Price be less than $0.50 per share. Repayment of principal on the Note, together with accrued interest thereon, is due in twelve monthly installments, commencing six months from issuance. The Company may make such payments in cash (in which event the Company will pay a 25% premium) or, subject to certain conditions, in shares of common stock valued at the lower of the Conversion Price or 70% of the average of the three (3) lowest Closing Sale Prices in the ten (10) Trading Days immediately preceding the applicable payment date.
Minimum [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Conversion price							$1
Maximum [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Conversion price							$3
Related Party [Member]
Related Party Debt (Textual)
Accounts payable, related parties												40,000			40,000
Maturity date												1-May-16
Joseph Andreae [Member]
Related Party Debt (Textual)
Accounts payable outstanding														12,828
Interest rate												6.00%		6.00%	6.00%
Notes payable, related parties												40,000		12,828	40,000
Accrued interest													1,348
Maturity date														30-Nov-14	1-May-16
Repayament of principal balance													40,000
Joseph Andreae [Member] \| Andreae Note II [Member]
Related Party Debt (Textual)
Accrued interest													240
Repayament of principal balance													12,828
Jerome Kaiser [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate																8.00%
Accrued interest	3,180		3,180
Maturity date																17-Mar-15
Future principal payments of related party notes payable																50,000
Notes payable																50,000
Principal amount	50,000		50,000
Discount related to beneficial conversion feature																10,000
Amortized discount to interest expense	1,667		6,667
Conversion description																The conversion price for the Kaiser Note is the market closing price of the market day immediately preceding the date of conversion minus twenty percent (20%).
Kyle [Member] \| 6% Note [Member]
Related Party Debt (Textual)
Interest rate												6.00%			6.00%
Notes payable, related parties						40,000						40,000			40,000
Interest expense related to notes payable						1,098
Conversion price						$1
Unamortized discount												13,333			13,333
Common stock issued on conversion						41,098
Discount related to beneficial conversion feature															16,000
Amortized discount to interest expense											6,667
Kyle Tracey [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate								8.00%
Accounts payable, related parties								10,612
Maturity date								18-Feb-16
Interest expense related to notes payable						584
Principal amount								10,612
Conversion price						$0.50
Unamortized discount								2,830
Common stock issued on conversion						22,481
Discount related to beneficial conversion feature								4,245
Amortized discount to interest expense											1,415
Conversion description								The conversion price for the Tracey Note was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Kyle Tracey Two [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate												8.00%			8.00%
Accounts payable, related parties												11,042			11,042
Maturity date															12-May-16
Interest expense related to notes payable						407
Principal amount												11,042			11,042
Conversion price						$0.50
Unamortized discount												3,497			3,497
Common stock issued on conversion						22,989
Discount related to beneficial conversion feature															4,417
Amortized discount to interest expense											920
Conversion description															The conversion price for the Tracey Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Michael Cook [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate												8.00%			8.00%
Accounts payable, related parties												11,825			11,825
Maturity date															12-May-16
Interest expense related to notes payable						435
Principal amount												11,825			11,825
Conversion price						$0.50
Unamortized discount												3,745			3,745
Common stock issued on conversion						24,619
Discount related to beneficial conversion feature															4,730
Amortized discount to interest expense											985
Conversion description															The conversion price for the Cook Note was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Mr. Cook [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate														8.00%
Accounts payable, related parties														15,115
Maturity date														11-Aug-16
Interest expense related to notes payable						255
Principal amount						15,115								15,115
Conversion price						$0.50
Unamortized discount														5,542
Common stock issued on conversion						30,864
Discount related to beneficial conversion feature														6,046
Conversion description														The conversion price for the Cook Note II was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Mr. Tracey [Member] \| 8% Convertible Note [Member]
Related Party Debt (Textual)
Interest rate														8.00%
Accounts payable, related parties														216,001
Maturity date														11-Aug-16
Interest expense related to notes payable						3,645
Principal amount						216,001								216,001
Conversion price						$0.50
Unamortized discount														79,200
Common stock issued on conversion						441,057
Discount related to beneficial conversion feature														86,401
Conversion description														The conversion price for the Tracey Note III was the lowest market closing price per share within the previous twenty (20) market days of the date of conversion minus a discount of forty percent (40%).
Shareholder [Member]
Related Party Debt (Textual)
Interest rate																	6.00%
Notes payable, related parties																	23,462
Accounts payable, related parties																				15,000
Accrued interest																			963
Maturity date																	1-Dec-16
Interest expense related to notes payable	226		457
Gain on extinguishment of debt																	3,462
Shareholder [Member] \| Subsequent Event [Member]
Related Party Debt (Textual)
Accrued interest																					1,504
Notes payable																					20,000
Investor [Member] \| 6% Note [Member]
Related Party Debt (Textual)
Principal amount																						$230,000

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	0 Months Ended	3 Months Ended			6 Months Ended		1 Months Ended
Commitments and Contingencies (Details) (USD $)	Dec. 15, 2015	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jan. 31, 2015	Sep. 30, 2014
Other Commitments [Line Items]
Change in warrant liability		($414,654)		$29,528,844	($1,824,479)	$29,528,844
Change in derivative liability					668,055
Warrant liability		639,753			639,753			2,464,232
Net proceeds from settlement			62,930		62,930
Vendor credits		325,000	200,000		325,000
Treasury stock, value		367,531			367,531
Treasury stock, shares		440,625			440,625
Gain on settlement		367,531			625,461
Loss on settlement of stock	257,930
Subsequent Event [Member]
Other Commitments [Line Items]
Common stock for compensation							440,625
Warrant [Member]
Other Commitments [Line Items]
Shares issued, price per share				$7.25		$7.25
Long term warrant liability				29,430,022		29,430,022
Closing stock shares				4,407,200		4,407,200
Change in derivative liability					625,461
Fair value of warrant liability		1,184,727			1,184,727
Warrant liability		$639,753			$639,753
Warrant [Member] \| Maximum [Member]
Other Commitments [Line Items]
Shares issued, price per share				$7.25		$7.25
Warrant [Member] \| Minimum [Member]
Other Commitments [Line Items]
Shares issued, price per share				$4.72		$4.72

Stockholders_Deficit_Details

Stockholders' Deficit (Details) (USD $)	6 Months Ended
Stockholders' Deficit (Details) (USD $)	Mar. 31, 2015
Warrant [Member]
STOCK OPTIONS/WARRANTS:
Options/ Warrants outstanding, Shares, Beginning balance	1,184,726
Options/ Warrants issued/granted
Option/ Warrants exercised
Cancelled/forfeited/expired
Options/ Warrants Outstanding, Shares, Ending Balance	1,184,726
Option/ Warrents Weighted Average Exercise Price, Beginning balance	$0.11
Option/ Warrents issued/granted, Weighted Average Exercise Price
Option/ Warrents exercised, Weighted Average Exercise Price
Option/ Warrents Cancelled/forfeited/expired, Weighted Average Exercise Price
Option/ Warrents Weighted Average Exercise Price, Ending Balance	$0.11
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Beginning	1 year 7 months 6 days
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Ending	1 year 2 months 12 days
Option/ Warrents Outstanding, Aggregate Intrinsic Value, Beginning balance	$7,217,234
Option/ Warrents Outstanding, Aggregate Intrinsic value, Balance	896,696
Stock Options [Member]
STOCK OPTIONS/WARRANTS:
Options/ Warrants outstanding, Shares, Beginning balance	1,150,000
Options/ Warrants issued/granted	995,000
Option/ Warrants exercised
Cancelled/forfeited/expired	-145,000
Options/ Warrants Outstanding, Shares, Ending Balance	2,000,000
Options/ Warrants exercisable, Shares	751,250
Option/ Warrents Weighted Average Exercise Price, Beginning balance	$2.92
Option/ Warrents issued/granted, Weighted Average Exercise Price	$0.73
Option/ Warrents exercised, Weighted Average Exercise Price
Option/ Warrents Cancelled/forfeited/expired, Weighted Average Exercise Price	$11.61
Option/ Warrents Weighted Average Exercise Price, Ending Balance	$1.20
Options/ Warrants exercisable, Weighted Average Exercise Price	$1.36
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Beginning	8 years 8 months 12 days
Options/ Warrants granted, Weighted Average Remaining Contractual Term	10 years
Options/ Warrants cancelled/forfeited/expired, Weighted Average Remaining Contractual Term	9 years 2 months 12 days
Options/ Warrants outstanding, Weighted Average Remaining Contractual Term, Ending	9 years 8 months 12 days
Options/ Warrants exercisable, Weighted Average Remaining Contractual Term	9 years 7 months 6 days
Option/ Warrents Outstanding, Aggregate Intrinsic Value, Beginning balance	4,648,294
Option/ Warrents Outstanding, Aggregate Intrinsic value, Balance	317,629
Options/ Warrants exercisable, Aggregate Intrinsic value	$79,407

Stockholders_Deficit_Details_T

Stockholders' Deficit (Details Textual) (USD $)

0 Months Ended

1 Months Ended

6 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

3 Months Ended

12 Months Ended

6 Months Ended

1 Months Ended

0 Months Ended

Feb. 11, 2014

Jun. 27, 2014

Mar. 31, 2015

Oct. 20, 2014

Dec. 22, 2014

Dec. 31, 2013

Sep. 30, 2014

Mar. 31, 2014

Jun. 19, 2014

Mar. 12, 2015

Dec. 03, 2014

Jan. 31, 2014

Aug. 11, 2014

Employee

Stockholders' Deficit (Textual)

Common stock, shares authorized

1,000,000,000

Preferred stock, shares authorized

100,000,000

Convertible price, description

The conversion price of these 6% Notes is the average of the fifteen (15) lowest daily VWAPs occurring during the twenty (20) consecutive trading days immediately preceding the date each Holder elects convert all of their 6% Note minus a discount of 40%.

Shares authorized

2,000,000

Principal amount

$500,000

Common stock issued for services

36,769

Conversion of unpaid wages

96,487

Cost of Revenue [Member]

Stockholders' Deficit (Textual)

Fair value of the stock vested issuance

9,150

Selling and Marketing Expense [Member]

Stockholders' Deficit (Textual)

Fair value of the stock vested issuance

9,150

General and Administrative Expense [Member]

Stockholders' Deficit (Textual)

Fair value of the stock vested issuance

195,200

Under 2014 Stock Option Plan [Member]

Stockholders' Deficit (Textual)

Vesting rights, Description

The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant.

Options/ Warrants issued/granted

20,000

775,000

Stock option cancelled

20,000

225,000

Option/ Warrents Granted, Weighted Average Exercise Price

$0.83

$0.70

Stock option granted value

16,600

542,500

Share-based compensation expense

4,150

135,625

Number of options vested

5,000

193,750

Stock Options [Member]

Stockholders' Deficit (Textual)

Options/ Warrants issued/granted

995,000

Stock option cancelled

-145,000

Option/ Warrents Granted, Weighted Average Exercise Price

$0.73

Share-based compensation expense

466,587

537,849

Non Employeeb Stock Option [Member]

Stockholders' Deficit (Textual)

Share-based compensation expense

71,262

September 30, 2015 [Member] | Stock Options [Member]

Stockholders' Deficit (Textual)

Share-based compensation expense

466,587

September 30, 2015 [Member] | Non Employeeb Stock Option [Member]

Stockholders' Deficit (Textual)

Share-based compensation expense

21,167

September 30, 2016 [Member] | Stock Options [Member]

Stockholders' Deficit (Textual)

Share-based compensation expense

606,362

September 30, 2016 [Member] | Non Employeeb Stock Option [Member]

Stockholders' Deficit (Textual)

Share-based compensation expense

42,333

Consulting Agreements [Member]

Stockholders' Deficit (Textual)

Vesting rights, Description

The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant.

Options/ Warrants issued/granted

200,000

Option/ Warrents Granted, Weighted Average Exercise Price

$0.83

Stock option granted value

166,000

Options to purchase shares

100,000

Share-based compensation expense

41,500

Additional expenses

3,000

Non employee options

200,000

Number of options vested

50,000

Subsequent Event [Member]

Stockholders' Deficit (Textual)

Vesting rights, Description

The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant.

Option/ Warrents Granted, Weighted Average Exercise Price

$0.70

Options to purchase shares

175,000

Principal amount

560,000

10% Convertible Note [Member]

Stockholders' Deficit (Textual)

Principal amount

100,000

Series A Preferred Stock

Stockholders' Deficit (Textual)

Shares issued during period

500,000

Preferred stock, shares authorized

500,000

Common stock issued for bonuses, Shares

Common Stock [Member]

Stockholders' Deficit (Textual)

Common stock issued for services, Shares

60,277

Common stock issued for services

Conversion of unpaid wages share

158,175

Conversion of unpaid wages

Common stock issued for bonuses, Shares

440,001

Preferred Stock [Member]

Stockholders' Deficit (Textual)

Shares issued during period

500,000

Preferred stock, shares authorized

100,000,000

Description of asset purchase agreement

Series A Shares are entitled to vote at a 15-1 ratio to Common Stock

Kyle Tracey [Member]

Stockholders' Deficit (Textual)

Options/ Warrants issued/granted

60,000

Conversion of unpaid wages share

97,898

Conversion of unpaid wages

59,718

Common stock issued for bonuses, Shares

30,000

Additional shares of restricted common stock, Granted

100,000

Number Of Employee

Chief Executive Officer [Member]

Stockholders' Deficit (Textual)

Options to purchase shares

100,000

175,000

Chief Executive Officer [Member] | Subsequent Event [Member]

Stockholders' Deficit (Textual)

Options/ Warrants issued/granted

30,000

25,000

Principal amount

216,001

Board Of Directors And Shareholders [Member]

Stockholders' Deficit (Textual)

Vesting rights, Description

The options vest 25% at grant and 25% each subsequent six (6) months from the date of grant.

Options/ Warrants issued/granted

1,000,000

775,000

Option/ Warrents Granted, Weighted Average Exercise Price

1.66

Stock option granted value

1,000,000

Options to purchase shares

520,000

225,000

Share-based compensation expense

1,660,000

Compensation cost upon grant date

415,000

Additional expenses

22,312

Non employee options

212,500

Number of options vested

250,000

Consultant [Member]

Stockholders' Deficit (Textual)

Convertible price, description

A one-time pro rata adjustment of up to ten-for-one (10-1) based upon the Company generating aggregate gross revenues over the two years of at least $8,000,000 (e.g. If the Company generates only $4,000,000 in aggregate gross revenues over the two year period then the convertible ratio will adjust to 5-1). In no event will the issuance convert into more than 5,000,000 shares of common stock of the Company.

Joseph Andreae [Member]

Stockholders' Deficit (Textual)

Options to purchase shares

190,000

175,000

Joseph Andreae [Member] | Subsequent Event [Member]

Stockholders' Deficit (Textual)

Options/ Warrants issued/granted

30,000

Principal amount

12,828

Chief Financial Officer [Member]

Stockholders' Deficit (Textual)

Options to purchase shares

175,000

Michael Cook [Member]

Stockholders' Deficit (Textual)

Options to purchase shares

25,000

Conversion of unpaid wages share

60,277

Conversion of unpaid wages

36,769

Michael Cook [Member] | Subsequent Event [Member]

Stockholders' Deficit (Textual)

Principal amount

$15,115

Intellectual_Property_Details

Intellectual Property (Details) (USD $)	Mar. 31, 2015	Sep. 30, 2014
Intellectual Property (Textual)
Trademarks	$123,150	$119,575
Pending patents	20,420	14,890
Patents [Member]
Intellectual Property (Textual)
Pending patents	20,420
Trademarks [Member]
Intellectual Property (Textual)
Trademarks	$123,150

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended				6 Months Ended
Segment Information (Details) (USD $)	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Revenue
Ceramics	$396,100		$30,759		$782,743		$30,759
Merchandise	19,159				19,159
Total revenue	415,259		30,759		801,902		30,759
Cost of revenue
Ceramics	280,828	[1]	9,621	[1]	430,714	[1]	9,621	[1]
Merchandise	16,814				16,814
Total cost of revenue	297,642		9,621		447,528		9,621
Gross Profit	117,617		21,138		354,374		21,138
Operating expense:
Sales and Marketing	296,058	[2]		[2]	365,338	[2]		[2]
Research and development	200		29,087		52,053		37,587
General and administrative	398,343	[3]	207,851	[3]	1,373,050	[3]	418,170	[3]
Total operating expenses	694,601		236,938		1,790,441		455,757
Operating loss	-576,984		-215,800		-1,436,067		-434,619
Other income (expense):
Interest expense	93,488		51,659		171,478		51,659
Interest expense - related party	6,587		9,061		152,150		57,569
Change in warrant liability	-414,654		29,528,844		-1,824,479		29,528,844
Gain on settlement	367,531				625,461
Loss on debt modification	19,981				19,981
Total other income, net	662,129		-29,589,564		2,106,331		-29,638,072
Income before provision for income taxes	85,145		-29,805,364		670,264		-30,072,691
Provision for income taxes					2,209
Net income	85,145		-29,805,364		668,055		-30,072,691
VAPE [Member]
Revenue
Ceramics
Merchandise
Total revenue
Cost of revenue
Ceramics
Merchandise
Total cost of revenue
Gross Profit
Operating expense:
Sales and Marketing	3,777				5,778
Research and development
General and administrative	246,395				675,671
Total operating expenses	250,173				681,449
Operating loss	-250,172				-681,449
Other income (expense):
Interest expense - related party
Change in warrant liability
Gain on settlement
Loss on debt modification
Total other income, net
Income before provision for income taxes
Provision for income taxes
Net income
HIVE [Member]
Revenue
Ceramics	396,100				782,743
Merchandise
Total revenue	396,100				782,743
Cost of revenue
Ceramics	280,828				430,714
Merchandise
Total cost of revenue	280,828				430,714
Gross Profit	115,272				352,029
Operating expense:
Sales and Marketing	274,294				365,786
Research and development	200				52,053
General and administrative	927,426				451,119
Total operating expenses	367,236				868,958
Operating loss	-252,963				-516,929
Other income (expense):
Interest expense - related party
Change in warrant liability
Gain on settlement
Loss on debt modification
Total other income, net
Income before provision for income taxes
Provision for income taxes
Net income
MARKETING [Member]
Revenue
Ceramics
Merchandise	19,159				19,159
Total revenue	19,159				19,159
Cost of revenue
Ceramics
Merchandise	16,814				16,814
Total cost of revenue	16,814				16,814
Gross Profit	2,345				2,345
Operating expense:
Sales and Marketing	17,987				17,987
Research and development
General and administrative	59,783				59,205
Total operating expenses	77,192				77,192
Operating loss	-74,847				-74,847
Other income (expense):
Interest expense - related party
Change in warrant liability
Gain on settlement
Loss on debt modification
Total other income, net
Income before provision for income taxes
Provision for income taxes
Net income

[1]	Stock-based compensation was $0 and $0, and $48,483 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.
[2]	Stock-based compensation was $0 and $0, and $140,886 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.
[3]	Stock-based compensation was $0 and $0, and $636,683 and $0 for the three and six months ended March 31, 2015 and 2014, respectively.

Subsequent_Events_Details

Subsequent Events (Details) (Subsequent Event [Member])	12 Months Ended
Subsequent Events (Details) (Subsequent Event [Member])	Apr. 30, 2017	Apr. 30, 2016
Up to $200,000 gross revenue [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage Of Gross Consulting Revenue	2.50%	25.00%
From $200,000 - $400,000 gross revenue [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage Of Gross Consulting Revenue	5.00%	5.00%
From $400,000 - $600,000 gross revenue Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage Of Gross Consulting Revenue	7.50%	7.50%
Above $600,000 gross revenue [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Percentage Of Gross Consulting Revenue	10.00%	10.00%

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)	6 Months Ended	0 Months Ended
Subsequent Events (Details Textual) (USD $)	Mar. 31, 2015	1-May-15	11-May-15
Subsequent Events (Textual)
Treasury stock, shares	440,625
$2M Securities Purchase Agreement [Member]
Subsequent Events (Textual)
Subsequent funding	$361,600
Subsequent Event [Member]
Subsequent Events (Textual)
Annual salary		$102,000
Gross revenue earned non industry related, description		50/50 share (payable monthly based on actual net revenue collections.
Percentage of net royalties received		0.15%
Percentage of net profit received		0.05%
Subsequent Event [Member] \| Officers, Employees And Consultants [Member]
Subsequent Events (Textual)
Stock options granted			1,005,000
Subsequent Event [Member] \| Chief Executive Officer, President and Chief Operating Officer [Member]
Subsequent Events (Textual)
Options exercise Price			1.66
Stock option forfeitured			190,000
Subsequent Event [Member] \| Former Business Development Officer [Member]
Subsequent Events (Textual)
Options exercise Price			1.66
Stock option forfeitured			100,000
Subsequent Event [Member] \| Employees [Member]
Subsequent Events (Textual)
Options exercise Price			1.66
Stock option forfeitured			117,500
Number of employees			3
Subsequent Event [Member] \| Consultants [Member]
Subsequent Events (Textual)
Options exercise Price			1.66
Stock option forfeitured			217,500